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ABSTRACT
Stochastic modeling of an HIV/AIDS
epidemic with treatment
Mozart Umba Nsuami
PhD Thesis, Department of Mathematics and Applied Mathematics, University of the
Western Cape.
The HIV/AIDS epidemic continues to be among the most devastating diseases in hu-
man history despite the new scientific advances and serious public health interventions.
The greatest burden of HIV/AIDS is still in sub-Saharan Africa, and within this specific
region, women are severely affected. Despite an increase in prevention interventions, in-
cluding such as ARV treatment and pre-exposure prophylaxis (PrEP), behavioural change
remains a key role in the transmission of HIV/AIDS. In this thesis, we investigate several
related models for the population dynamics of HIV/AIDS epidemic model with treatment.
We start off with a four compartmental HIV deterministic model with stages of HIV in-
fection and with inflow of HIV infectives. Thereafter, we impose stochastic perturbations
on the underlying HIV/AIDS deterministic model without inflow of infectives. For this
version of HIV stochastic model, we prove global existence and positivity of solutions to
the HIV/AIDS-perturbed model. Some useful properties such as boundedness property,
stochastic permanence property and asymptotic stability have been derived. Under the
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asymptotic stability, it is found that whenever the intensities of the noise are not too large,
then the stochastic solution remains close to the underlying deterministic solution. Oth-
erwise strong noise gives a divergence between stochastic and deterministic behaviours.
We also investigate another type of stochastic HIV model with inflow of infectives and
we study stability in the mean. In the absence of inflow of infectives, we introduce an
analogue of the basic reproduction number which we link to a theorem on almost sure
exponential stability in the case of a disease-free equilibrium. It is found that stochastic
perturbation does not destabilize the disease-free equilibrium, i.e., whenever the analogue
of the basic reproduction number is below unit, then the disease-free equilibrium is almost
surely exponentially stable. Furthermore, we propose a new model for the transmission of
HIV/AIDS including ART treatment and pre-exposure prophylaxis (PrEP). Our model
can be used to test the effects of ART and of the uptake of PrEP in a given population,
as we demonstrate through simulations. The model can also be used to estimate future
projections of HIV prevalence. We prove global stability of the disease-free equilibrium.
We also prove global stability of the endemic equilibrium for the most general case of the
model, i.e., which allows for PrEP individuals to default. We include insightful simula-
tions based on published South-African HIV trend from 2016. Finally, we also investigate
other stochastic HIV/AIDS epidemic models such as: stochastic HIV model with satu-
rated incidence rate and stochastic HIV model with the use of PrEP. The results obtained
in both models were very meaningful, and we show insightful simulations in this regard.
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Chapter 1
General Introduction
1.1 HIV/AIDS background
Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is
a disease of the human immune system caused by human immunodeficiency virus (HIV).
In the summer of 1981, clinicians in New York and California observed among young, pre-
viously healthy, homosexual men an unusual clustering of cases of rare diseases, notably
kaposi sarcoma and opportunistic infections such as Pneumocystis carinii pneumonia, as
well as cases of unexplained, persistent lymphadenopathy [30, 53]. It soon became evident
that these individuals had a common immunological deficit in cell-mediated immunity, re-
sulting predominantly from a significant diminution of circulating CD4+ T cells [33, 62].
Acquired Immune Deficiency Syndrome (AIDS) occurs when an HIV-positive individual
has such lowered immune levels that he/she falls prey to a variety of opportunistic infec-
tions. The rate of HIV infection and death due to AIDS first increased rapidly during the
1980s in the United States and in Western Europe. Since 1982 AIDS has developed into
a global pandemic across the world.
There are two types of HIV virus: HIV1 which is most common in sub-Saharan Africa
and throughout the world, and HIV2 which is most often found in West Central Africa,
5
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parts of Europe and India. It is important though to notice that both produce the same
patterns of illness. HIV2 causes a slower progression of disease than HIV1. HIV is the
virus that causes AIDS. Not everyone who is infected with HIV has AIDS. Everyone with
AIDS is infected with HIV. AIDS is the result of progression of HIV Infection. Anyone
infected with HIV, although healthy, can still transmit the virus to another person. The
HIV/AIDS pandemic consists of many separate epidemics. Each epidemic has its own
distinct origin, in terms of geography and specific populations affected, and involve differ-
ent types and frequencies of risk behaviours and practices, for example, unprotected sex
with multiple partners or sharing of drug injection equipment. It has been observed many
years ago that the virus cannot spread by means of a handshake, kiss, or a sneeze, nor by
means of a mosquito bite. Sharing of food, drinking glasses or clothes will not transmit
the virus. Thus the main means of transmission worldwide is human sexual intercourse
in which bodily fluids like semen or blood are exchanged. This is the reason why the
sexually active age group from 15 to 45 is most at risk. Also important in HIV transmis-
sion is the sharing of unclean needles, such as between injection drug users, and in rare
instances, the virus is transmitted by means of accidental needle-sticks. Mother-to-child
transmission (also called MTCT or vertical transmission) is common today, resulting in
millions of pediatric HIV cases. The chances of a baby born to an HIV plus mother being
infected are about 40 percent. Because mother-to child HIV transmission can be so easily
prevented (or at least minimized) by an anti-retroviral drug at a low cost, infected infants
are an especially painful problem for the world.
1.1.1 HIV/AIDS stages of infection
The process from HIV to AIDS may take several years and includes different stages, see
for instance in [102]. The WHO system for adults sorts patients into one of four hier-
archical clinical stages ranging from stage 1 (asymptomatic) to stage 4 (AIDS). Patients
are assigned to a particular stage when they demonstrate at least one clinical condition in
6
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that stage’s criteria. Patients remain at a higher stage after they recover from the clinical
condition which placed them in that stage. These stages are as follows.
1. Stage 1.
Patients who are asymptomatic or have persistent generalized lymphadenopathy
(lymphadenopathy of at least two sites [not including inguinal] for longer than 6
months) are categorized as being in stage 1, where they may remain for several
years.
2. Stage 2.
Even in early HIV infection, patients may demonstrate several clinical manifes-
tations. Clinical findings included in stage 2 (mildly symptomatic stage) are un-
explained weight loss of less than 10 percent of total body weight and recurrent
respiratory infections (such as sinusitis, bronchitis, otitis media, and pharyngitis),
as well as a range of dermatological conditions including herpes zoster flares, angular
cheilitis, recurrent oral ulcerations, papular pruritic eruptions, seborrhoeic dermati-
tis, and fungal nail infections.
3. Stage 3.
As disease progresses, additional clinical manifestations may appear. Those encom-
passed by the WHO clinical stage 3 (the moderately symptomatic stage) category
are weight loss of greater than 10 percent of total body weight, prolonged (more than
1 month) unexplained diarrhea, pulmonary tuberculosis, and severe systemic bacte-
rial infections including pneumonia, pyelonephritis, empyema, pyomyositis, meningi-
tis, bone and joint infections, and bacteremia. Mucocutaneous conditions, including
recurrent oral candidiasis, oral hairy leukoplakia, and acute necrotizing ulcerative
stomatitis, gingivitis, or periodontitis, may also occur at this stage.
7
http://etd.uwc.ac.za/
4. Stage 4.
The WHO clinical stage 4 (the severely symptomatic stage) designation includes
all of the AIDS-defining illnesses. Clinical manifestations for stage 4 disease that
allow presumptive diagnosis of AIDS to be made based on clinical findings alone
are HIV wasting syndrome, Pneumocystis pneumonia (PCP), recurrent severe or ra-
diological bacterial pneumonia, extrapulmonary tuberculosis, HIV encephalopathy,
CNS toxoplasmosis, chronic (more than 1 month) or orolabial herpes simplex infec-
tion, esophageal candidiasis, and Kaposi’s sarcoma. Other conditions that should
arouse suspicion that a patient is in clinical stage include cytomegaloviral (CMV)
infections (CMV retinitis or infection of organs other than the liver, spleen or lymph
nodes), extrapulmonary cryptococcosis, disseminated endemic mycoses (e.g., coccid-
iomycosis, penicilliosis, histoplasmosis), cryptosporidiosis, isosporiasis, disseminated
non-tuberculous mycobacteria infection, tracheal, bronchial or pulmonary candida
infection, visceral herpes simplex infection, acquired HIV-associated rectal fistula,
cerebral or B cell non-Hodgkin lymphoma, progressive multifocal leukoencephalopa-
thy (PML), and HIV-associated cardiomyopathy or nephropathy. Presence of these
conditions unaccompanied by the AIDS-defining illnesses, however, should prompt
confirmatory testing.
1.1.2 HIV/AIDS in the history
In recent years, the HIV/AIDS epidemic has been spreading at an alarming rate, and
the prevalence of HIV infection is still extremely high. It is reported that more than
35 million of people were living with HIV in 2012 compared to 36.5 million in 2016. It
is reported in [44] that 2.5 million people were newly infected in 2012 compared to 1.8
million in 2016. There has been 1.5 million AIDS-related causes of death worldwide in
2013 compared to 1 million in 2016 (UNAIDS DATA 2017, [46]). The most significant
advance in medical management of HIV infection includes two recommendations [110].
First, antiretroviral therapy (ART) should be initiated for everyone living with HIV at
8
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any CD4+ cell count. The HIV treatment reduces viral load to levels below the limits
of detection of the most sensitive clinical assays, resulting in a significant reconstitution
of the immune system [4]. The Global AIDS Update 2016 of the Joint United Nations
Programme on HIV/AIDS, reports that the global coverage of ART therapy reached ap-
proximately 46% at the end of 2015. The gains in treatment are largely responsible for a
26% decline in AIDS-related deaths globally since 2010, from an estimated 1.5 million in
2010, to 1.1 million in 2015. Despite this significant achievement, globally there has been
1.8 million new infections reported in 2015 [45]. Second, the use of daily oral pre-exposure
prophylaxis (PrEP) is recommended as a prevention choice for people at substantial risk
of HIV infection as part of combination prevention approaches. Substantial gaps remain
in understanding the trade-offs between costs and benefits of choosing alternative HIV
prevention strategies, such as the initiation of PrEP by high risk uninfected individuals
[29]. Following WHO, making PrEP drugs available for safe, effective prevention outside
the clinical trial setting is the current challenge. However, it is important to highlight and
recall that PrEP is not for everyone: only people who are HIV-negative and at very high
risk for HIV infection should take PrEP [111]. In 2015, the Medicines Control Council of
South Africa issued a full regulatory approval of PrEP, and the country became the first
in Sub-Saharan Africa to include PrEP in its national HIV programme. Globally, female
sex workers (FSWs) are 13.5 times more likely to be living with HIV than women in the
general population [50]. There are many countries with regulatory approval for PrEP.
The European Medicines Agency has also granted market authorization for PrEP to be
marketed across the European Union’s 28 countries [25].
South Africa is a country homing the largest concentration of people living with HIV
in the world. The first AIDS-related deaths in this country occurred in late December
1981 and January 1982 [79, 64]. The HIV epidemic was not an issue of major concern
to the government and therefore received a very limited attention [87]. The prevalence
of HIV/AIDS increased from 0.8% in 1990 to 4.3% in 1994, and almost 10% of the total
population in 2014 [63]. The provision of ART in 2013 has reduced the prevalence of
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HIV from an estimated 15% to 9% among adults not on ART. The annual incidence
decreased from 2% to 0.9% and the AIDS related deaths from 0.9% to 0.3% p.a., saving
1.5 million lives and US 727 million, see [104]. In April 2010, a large HIV counselling
and testing campaign was launched in South Africa, a principle part of which was to
scale up awareness of HIV [34, 42] and the result was positive. In [36], a model based
on the case scenario of 90% annual HIV testing coverage in adults 15− 49 years old and
four ART eligibility scenarios of CD4+ count has been studied. The authors found that
increasing the provision of ART to less than 350 cells /mm3 may significantly reduce
costs while reducing the HIV burden. In the paper [104] the authors use trend data for
the prevalence of HIV among woman attending ante-natal clinics in South Africa and
the reported coverage of ART. The authors found that a main reason why countries of
Southern Africa have the highest rates of HIV in the world is because of the system of
oscillating migrant labour historically.
1.1.3 HIV/AIDS Treatment
HIV treatment is actually deeply affecting the epidemic in countries where it has been
brought to scale. Antiretroviral treatment is usually started once an individuals CD4+
count (the number of T helper cells) drops to a low level, an indication that the immune
system is deteriorating. Treatment can stop HIV from damaging the immune system,
therefore, HIV-infected individuals on treatment usually remain clinically asymptomatic.
Accelerating the scale up of antiretroviral therapy will drive progress across the broader
AIDS response. It will reduce HIV-related illness and death, prevent people from ac-
quiring HIV infection, address the needs of women and girls, reduce stigma and social
exclusion and promote service integration.
In the rapidly developing countries most heavily affected by HIV, scaling up antiretrovi-
ral therapy preserves and strengthens the health and well-being of the adolescents and
working-age adults on which future economic growth depends. Investing in HIV treatment
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generates economic returns up to three times the investment, increasing productivity, pre-
venting children from becoming orphaned and deferring the health care costs associated
with advanced HIV-related illnesses [94, 81].
In South Africa, where HIV treatment coverage reached 83% in 2012 under WHOs 2010
treatment guidelines [94, 109, 103] (initiating treatment at a CD4+ cell count of 350
cells/mm3), scaling up treatment is estimated to have reduced the number of people
newly infected with HIV by 17-32% in 2011 [94, 23]. In KwaZulu-Natal, South Africa,
life expectancy in 2011 was 11.3 years greater than in 2003, when HIV treatment in the
province began to be scaled up [10]. In parts of KwaZulu-Natal where a substantial level
of HIV treatment coverage (30−40%) had been achieved, the odds of acquiring HIV were
38% lower than in communities in which fewer than 10% of treatment-eligible individuals
were receiving therapy [92].
However, in HIV-infected individuals not receiving treatment or on treatment that is not
working, the immune system fails and symptoms develop. Initially many of the symptoms
are mild, but as the immune system deteriorates the symptoms worsen. Symptomatic HIV
infection is mainly caused by the emergence of certain opportunistic infections that the
immune system would normally prevent. This stage of HIV infection is often characterised
by multi-system disease and infections can occur in almost all body systems. Treatment
for the specific infection is often carried out, but the underlying cause is the action of HIV
as it erodes the immune system. Unless HIV itself can be slowed down the symptoms of
immune suppression will continue to worsen.
1.2 Research questions, aims and objectives
The major objectives of this research are the construction and analysis of determinis-
tic and stochastic models for the population dynamics of HIV/AIDS disease. We shall
build a mathematical model or models for the numerical dynamics of the disease in a
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population, that will be able to make future projections and to assess or plan for inter-
ventions towards curbing the disease. This work entails literature searching, pencil and
paper mathematical investigation, and computer code writing and then running such code.
In this dissertation, we address the following matters:
1. Should HIV/AIDS be considered as a chronic manageable disease rather than a fatal
one?
2. What is the impact of inflow of infectives on the epidemiology of HIV/AIDS?
3. What is the extent to which ARV treatment and pre-exposure prophylaxis (PrEP)
significantly help to reduce the endemicity of the disease in a population?
4. What is the impact of the incidence rate on the force of infection?
5. Would the environmental perturbation be catastrophic on the system and prevent
the policy makers to launch a certain intervention programme?
6. How can public health authorities optimally intervene on the epidemic?
1.3 Literature review
The dynamics between virus infections and the immune system involve many different
components. In such cases, the principles governing the dynamics and the outcome of
infection cannot be understood by verbal or graphical reasoning. Thus mathematical
modeling in epidemiology has become a very powerful tool in analyzing the spread, and
control of infectious diseases qualitatively and quantitatively. The research results help to
predict and develop tendencies of the infectious disease, for determining the key factors of
the disease spreading, and for seeking the optimum strategies for preventing and control-
ling the spread of infectious diseases [59]. In [39] the authors show that the implications
of parents in perceptions of HIV counselling and testing are meaningful. Through the use
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of semi-structured interviews, qualitative study explored perceptions of parents regarding
the ethico-legal and social implications in the process of fighting against HIV/AIDS.
Cai et al. [14] investigate an HIV/AIDS epidemic model with two stages of infections.
The authors study local and global stability of the equilibria of a deterministic HIV/AIDS
model with treatment. Z. Osman et al. [75] extend the model of Cai et al. in [14] by
introducing the infectives through vertical transmission at any time t. The authors prove
global stability of the disease-free as well as the endemic equilibrium.
Research shows that access to treatment increases the expected available time for the
transmission of HIV, but it is also shown that treatment without reduction of risky be-
haviour may even increase the proportions of infected individuals. Such cases have been
studied in [14, 5]. In the paper by S. Blower [7], it is shown that incidence rates of HIV
will decrease due to the fact that more HIV-positive individuals gain access to treatment,
and hopefully the treated individuals would change their behaviour and the levels of risky
behaviour do not increase.
Many papers, whether in deterministic modeling or stochastic modeling, have studied
the effect of migrants on established populations. These papers study the stability of
equilibrium states and /or control of the spread of the disease. In general, there are two
types of stability analysis, local and global, widely used in the literature. Local stabil-
ity is concerned with behaviour of the model solution near an equilibrium point, while
global stability can describe solution behaviour in the whole domain. Examples of such
contributions can be found in [43, 68, 82, 95]. In the paper [68] of R. Naresh et al., the
authors analyze a mathematical model of the spread of HIV/AIDS in a population of
varying size with immigration of infectives. On analyzing this situation, they found that
the disease is always persistent if the direct immigration of infectives is allowed in the
community. However, in the absence of inflow of infectives, the endemicity of the disease
is found to be higher if pre-AIDS individuals also interact sexually, in comparison to the
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case when they do not. The paper [82] of T. Roy et al. describes and studies the preva-
lence of risky behaviours and factors affecting sexual practices among rural-to-urban male
migrant taxi drivers. Based on a survey, the authors’ results demonstrate that rural-to-
urban male migrants in the region under consideration significantly increase the spread of
sexually transmitted infections and HIV because of their mobility, their high-risk sexual
practices and their extensive sexual networks. In [95] the authors analyze a model of
HIV/AIDS transmission with infective immigrants with time delay and treatment. The
model incorporates some essential parameters of the HIV/AIDS transmission and enables
the assessment of the effect of recruitment of infected immigrants into the community.
They found that the direct inflow of infectives makes the disease more difficult to control.
PrEP can be cost-saving if delivered to individuals at increased risk of infection. The word
prophylaxis means to prevent or control the spread of an infection or disease. PREP is
a new HIV prevention method in which people who do not have HIV infection take a
pill daily to reduce their risk of becoming infected. In particular, HIV models that ac-
count for the use of PrEP are featured in the papers [86, 66, 37]. In [86] for instance,
a mathematical model for HIV/AIDS transmission using PrEP has been proposed, and
then translated into a control problem where the objective was to determine the PrEP
strategy that minimizes the number of individuals with pre-AIDS HIV-infection as well
as the costs associated with PrEP. The paper by Mukandavire et al. [66] compares the
impact of increasing condom use or HIV PrEP use among sex workers. The authors
found that condom promotion interventions should remain the mainstay HIV prevention
strategy for FSWs, with PrEP only being implemented once condom interventions have
been maximised or to fill prevention gaps where condoms cannot be used. In [37], the
authors develop a static model of HIV risk and compare HIV-risk estimates before and
after the introduction of PrEP to determine the maximum tolerated reductions in condom
use with regular partners and clients for HIV risk not to change. With a case study in
South Africa for FSWs, it is found that PrEP is likely to be of benefit in reducing HIV
risk, even if reductions in condom use do occur.
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The models mentioned so far are deterministic and do not consider explicitly the stochas-
ticities in or on the system. As a matter of fact, when modeling population dynamics, it
is also important to consider environmental fluctuations due to the fact that parameters
involved in epidemic models are not absolutely constant. They may fluctuate around
some average values. In the real world, population dynamics is inevitably subjected to
environmental noise, which is an important component for the population dynamics of
HIV/AIDS. The large white noise may be a serious epidemic, which can be considered
as the decisive factor responsible for the extinction of populations and human activi-
ties without control will affect the biological diffusion process which is likely to cause
fatal consequences [118]. Based on these facts, the research towards stochastic pop-
ulation systems became very interesting and valuable. Stochastic models for the epi-
demic populations have been proposed or developed by many authors; see for instance
[60, 19, 38, 28, 76, 52, 58, 93, 107, 78, 100]. Stochastic models involved in a certain eco-
logical relationship are also featured in [74, 91].
In [58], the authors obtain sufficient criteria for the existence of periodic solutions to deter-
ministic epidemic models with modified saturation incidence rates and their corresponding
stochastic epidemic models with random perturbation. The authors also utilise stochastic
Lyapunov functions to investigate the asymptotic behaviour of the solution. In [76], a
stochastic mutualism model is proposed and investigated. The authors show that there
is a unique solution to the model for any positive initial value. They also further show
that the solution is stochastically bounded, uniformly continuous and globally attractive.
Under some conditions, they show that the stochastic model is stochastically permanent
and persistent in mean. One of the topics that has been studied quite extensively in sde
models, is the stability of solutions, especially of the disease free equilibrium. There are
various versions of stability, see e.g. in [60]. Now it is known that stochastic perturbations
can stabilize a system. This is true also in epidemiological models. Although many papers
have studied stability, very few of these have proofs of stability of the disease free equi-
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librium beyond the condition R0 < 1. Here R0 denotes the basic reproduction number
of the underlying deterministic model. Examples of stochastic perturbation improving
stability of the disease-free equilibrium of an epidemic model of can be found in [38, 19].
In [78], the author investigates an SIR epidemic model with stochastic perturbations.
Some qualitative properties such as stochastic boundedness and permanence are proved.
X. X. Wang et al. [100] formulate and analyse a modified stochastic ratio-dependent
Leslie-Gower predator-prey model. Thus by applying Itoˆ formula and constructing Lya-
punov functions, some qualitative properties as well such as the existence of global positive
solutions, stochastic boundedness, and the global asymptotic stability are explored. Based
on these results, they perform a series of numerical simulations and make a comparative
analysis of the stability of the model system within deterministic and stochastic environ-
ments. In [52], an SIRS epidemic model with saturated incidence rate and disease-inflicted
mortality is studied. The Global stability of the endemic equilibrium state is proved by
constructing a Lyapunov function. The investigation of the authors stochastic model re-
vealed that the stochastic stability of disease free equilibrium depends on the magnitude
of the intensity of noise as well as the parameters involved within the model system. In
[99] the authors extend the classical SIRS epidemic model incorporating media coverage
from a deterministic framework to a stochastic differential equation (SDE) and focus on
how environmental fluctuations of the contact coefficient affect the extinction of the dis-
ease. It is shown that the magnitude of environmental fluctuations will have an effective
impact on the control and spread of infectious diseases.
Examples of stochastic models for HIV/AIDS can be found in [113, 26, 47]. In [26], the
authors study a model of AIDS and condom use via the technique of parameter perturba-
tion which is standard in stochastic population modeling. Their research indicates that
introducing environmental noise into the deterministic model can have a stabilising ef-
fect. The paper by Yang et al. [113] investigates the dynamic behaviour of an HIV model
with stochastic perturbation and the authors obtain the asymptotic behaviour results.
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Kamina et al. [47] apply the multi-dimensional diffusion process to model early human
immunodeficiency virus type-1 (HIV-1) population dynamics. The authors incorporate
more of the randomness of the HIV-1 infection process to investigate the probability and
the possibility of viral extinction in their model.
Many authors investigate asymptotic behaviour of stochastic systems around the equi-
libria of the underlying deterministic models and examples of those can be found in
[28, 57, 116, 117, 51, 114].
1.4 Outline of the thesis
This thesis is structured as follows:
Chapter 1 provides a general introduction on HIV/AIDS epidemic, biological background
on the disease in question. It also covers literature review on mathematical modeling of
HIV/AIDS, deterministic and stochastic models.
Chapter 2 produces background preliminaries on epidemiological modeling; some theories
of ordinary differential equations as well as stochastic differential equations.
In chapter 3 we start off first by presenting the relevant HIV/AIDS epidemic model with
two infection stages and inflow of infectives. We perform stability analysis of both the
disease-free and endemic equilibrium points.
In Chapter 4 we investigate stochastic dynamics of an HIV/AIDS epidemic model with
treatment. We show different approaches of introducing randomness in the model. We
prove existence of global positive solutions. Some useful properties such as boundedness,
stochastic permanence and asymptotic behaviour around the equilibrium of the underly-
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ing deterministic model are also studied.
In Chapter 5 we introduce a stochastic HIV/AIDS epidemic model with inflow of infec-
tives. A Theorem on almost sure exponential stability is studied in the absence of inflow
of infectives. Furthermore, we study stability in the mean.
In Chapter 6 we investigate a model describing the population dynamics of HIV/AIDS
including treatment and pre-exposure prophylaxis (PrEP) in the context of South Africa.
In Chapter 7 we propose a stochastic model of HIV/AIDS epidemic with saturated in-
cidence rate. Our aim is this chapter is to investigate both the impact of the stochastic
perturbation as well as that of the incidence rate on the transmission HIV.
Chapter 8 is devoted to study exponential stability of a disease-free equilibrium for an
HIV epidemic model with the use of prophylaxis.
In Chapter 9 we give some concluding remarks, including insightful and constructive ideas
for future research.
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Chapter 2
Preliminaries
2.1 Existence and uniqueness of solutions
We start off by presenting a general theorem about existence and uniqueness of solutions
of the first order initial value problem and we shall refer to [27]. Consider an ordinary
differential equation (ODE):
x′(t) = f(t, x(t)), x(t0) = x0, (2.1)
where t0 and x0 are real numbers. Thus we shall show that if f(t, x) and ∂f∂x(t, x) are con-
tinuous in some region containing the point (t0, x0), then there is an interval (containing
t0) on which a unique solution of equation (2.1) exists.
Theorem 2.1.1. ([27]) Let f(t, x) be continuous for all values t and x. Then the initial
value problem is equivalent to the integral equation
x(t) = x0 +
∫ t
t0
f(s, x(s))ds (2.2)
in the sense that x(t) is a solution of (2.1) if and only if x(t) is a solution of (2.2).
Let D denote the rectangular region in the tx-plane defined by
D : a ≤ t ≤ b, c ≤ x ≤ d, (2.3)
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where −∞ < a < b < +∞ and −∞ < c < d < +∞. We say that the function f(t, x) is
Lipschitz continuous in x over D if there exists a constant k, 0 < k <∞, such that
|f(t, x1)− f(t, x2)| ≤ k|x1 − x2| (2.4)
whenever (t, x1) and (t, x2) belong to D. The constant k is called a Lipschitz constant.
Clearly, every Lipschitz continuous function is continuous in x for each fixed t. However,
not every continuous function is Lipschitz continuous.
Theorem 2.1.2. [20] Let f(t, x) and ∂f
∂x
(t, x) be continuous on D. Then f(t, x) is Lips-
chitz continuous in x over D.
Definition 2.1.3. ([61, 73, 83]) Equilibrium and stability
A point x∗ is an equilibrium solution of (2.1) if f(t, x∗) = 0. We say an equilibrium point
is
1. locally stable, if for every R > 0 there exists r > 0, such that
‖x(0)− x∗‖ < r ⇒ ‖x(t)− x∗‖ < R, t ≥ 0
2. locally asymptotically stable, if locally stable and
‖x(0)− x∗‖ < r ⇒ lim
t→∞x(t) = x
∗
3. globally asymptotically stable, asymptotically stable for all x(0) ∈ Rn .
Theorem 2.1.4. Lyapunov Global Asymptotic Stability
Let x˙ = f(x) and f(x∗) = 0. If there exists a C1 function V : Rn → R such that
1. V (x∗) = 0
2. V (x) > 0, for all x 6= x∗
3. V˙ (x) < 0 for all x 6= x∗
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4. V (x)→∞ as ‖x‖ → ∞
then x∗ is a globally asymptotically stable equilibrium.
Definition 2.1.5. Invariant Sets
A set M is called invariant if for the system
x˙ = f(x),
x(0) ∈M implies that x(t) ∈M for all t ≥ 0.
2.2 Compartment Modeling
A compartmental disease model is one for which the individuals in a population are
classified into compartments depending on their status with regard to the infection under
study and assumptions about the nature and time rate of transfer from one compartment
to another. The standard susceptible-exposed-infectious-removed (SEIR) model divides
the total population into four compartments: susceptible (S, previously unexposed to
the pathogen), exposed (E, infected, but not yet infectious), infected (I, infected and
infectious) and recovered (R, recovered from infection and acquired lifelong immunity)
[3, 49, 1]. The infection process is represented in Figure 2.1. Children are born susceptible
to the disease and enter the compartment S. A susceptible individual in compartment S
is infected after effective contact with an infectious individual in compartment I and then
enters the exposed compartment E. After the latent period ends, the individual enters the
compartment I and becomes capable of transmitting the infection. When the infectious
period ends, the individual enters the recovered class R and will never be infected again
[49, 1]. In each compartment, individual death occurs at a constant rate, µ, which is
equal to the birth rate. Death induced by the disease is not considered here. Therefore,
the total population size in the model, N , remains unchanged. The SEIR model and its
extension have been used to model many infectious diseases, for example, measles [2, 17],
rubella [31, 13], influenza [35, 18] and SARS [56, 101], among others.
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Figure 2.1: Structure of a susceptible-exposed-infectious-recovered (SEIR) model.
where the parameter α is the rate at which individuals in the exposed category become
infectious per unit time, and its reciprocal is the average latent period; the parameter γ
is the rate at which infectious individuals recover (become immune) per unit time, and
its reciprocal is the average infectious period; and the parameter µ refers to the birth
and death rates. The probability per unit of time at which the susceptible individuals
of the population become infected is called force of infection which is represented by λ.
The latter generally seen as a function of total number of infective individuals. The term
incidence represents the number of individuals that become infected in any given period
of time. It is often referred to as incidence rate, which is the incidence per unit time.
Prevalence is defined as the proportion of the population that is infected.
2.2.1 HIV/AIDS compartment modeling
For the case of HIV/AIDS modeling, we can also refer in [6, 54, 14, 88]. In [6] for
instance, a model for HIV/AIDS in four compartment is presented. The total sexually-
active population at time t, is denoted by N(t). This population N(t) is divided into four
mutually-exclusive compartments, namely susceptible class S(t), the infected individuals
who do not know that they are infected I1(t), the infected individuals who do know that
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they are infected I2(t), and that of the AIDS populations A(t). Hence the total population
at time t, N(t) can be written as N(t) = S(t) + I1(t) + I2(t) + I1(t). It is assumed that
individuals are recruited at a constant rate pi to the susceptible class S(t). Susceptible
individuals can be infected with HIV following contact with infected individuals at a rate
λ, where λ = β1λ1+β2λ2
N
, with β1, β2 are the transmission rates for HIV. The individuals
in the I2 class are more infectious than those in the I1 class. Therefore we must have
β1 < β2. Suppose that the individuals of the I1(t) class enter into the I2(t) class at a rate
ω and into the AIDS class A(t) at a rate δ1. Again suppose that the individuals of the
I2(t) class progress into the AIDS class at a rate I2(t). Let µ and d denote the natural
mortality rate and disease induced death rate respectively.
In [88], the authors present a mathematical model for the transmission dynamics of
HIV/AIDS epidemic with treatment by considering the three latent compartments for
slow, medium and fast progresses of developing the AIDS. The model is developed by
dividing the total population into six compartments, namely susceptible compartment S,
slow latent compartment I1, medium compartment I2, fast latent compartment I3, symp-
tomatic stage J and a full-blown AIDS A group. Thus, the total number of population
at time t is given by
N(t) = S(t) + I1(t) + I2(t) + I3(t) + J(t) + A(t).
In the paper by Cai et al., [14], an HIV/AIDS epidemic treatment model is presented. To
construct the model, the authors first divide the total population into four classes. The
classes are: the class of susceptible individuals S(t), the class of asymptomatic individ-
uals I(t), the class of symptomatic individuals J(t) and the class of the population who
have full-blown AIDS A(t). The term µK is the recruitment rate into the population,
µ being the birth rate which is assumed to coincide with the average mortality rate by
natural causes. The disease-induced mortality rate is denoted by δ. The parameters β;
βbdenote the probabilities of disease transmission per contact by an infective in the first
and second stage respectively. For an individual, c is the average number of contacts with
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others per unit time. By k1 and k2 we denote the transfer rates from the asymptomatic
phase I to the symptomatic phase J and from the symptomatic phase to the A-class,
respectively. The parameter α is the rate of transfer from the symptomatic phase J to
the asymptomatic phase I due to treatment.
The structure of the model is given by the following diagram:
A J
S I
βS(I + bJ)c
k1I
k2J
αJ
(µ+ δ)A
µS
µK
µJ
µI
Figure 2.2: Flow diagram of an HIV/AIDS model
2.2.2 Basic Reproduction number R0
The basic reproduction number can be obtained by inspection in models with only one
infective class. How ever if number of infective classes is two or more, then the technique
due to Diekmann (1990) is more appropriate. The technique has also been studied by
Van den Driessche and Watmough (2002) [11], Hyman et al. (2004) [41]. The technique
is called the next generation method and defines R0 as the spectral radius of the next
generator operator.
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2.2.3 R0 using the next generation method
Let us assume that there are n compartments of which m are infected. We define the
vector x = (x1, ..., xn)T , where xi ≥ 0 denotes the number of proportion of individuals
in the ith compartment. For simplicity we sort the compartments so that the first m
compartments correspond to infected individuals.
Define Xs to be set of all disease free states, that is
Xs = {x ≥ 0|xi = 0, i = 1, 2, ...m}.
Let Fi(x) be the rate of appearance of new infections in compartment i and let Vi(x) =
V −i (x)− V +i (x), where V +i is the rate of transfer of individuals into compartment i by all
other means and V −i is the rate of transfer of indivuals out of the ith compartment.
The disease transmission model consists of nonnegative initial conditions together with
the following system of equations:
x˙i = fi(x) = Fi(x)− Vi(x) (2.5)
Let us consider the following assumptions as in [11]:
1. If x ≥ 0, then Fi,V−i ,V+i ≥ 0 for i = 1, 2, ..., n.
It is noted that in the case where the compartment is empty, then there can be no
transfer of individuals out of the compartment by death, infection nor any other
means.
2. If xi = 0, then V−i = 0. This simply means that nobody leaves the compartment.
In particular if x ∈ Xs, then V−i = 0 for i = 1, 2, ...,m.
3. If Fi = 0, i > m. (m is the number of infectives classes)
4. If x ∈ Xs, then Fi = 0, and Vi = 0 for all i = 1, 2, ...,m.
5. If F(x) is set to zero, then all the eigenvalues of Df(x0) have negative real parts
and Df(x0) is the derivative
[
∂f1
∂xj
]
evaluated at the disease free equilibrium x0.
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Assuming that Fi and Vi meet the assumptions above, we can form the next generation
matrix FV −1 from the matrices of partial derivatives of Fi and Vi. More specifically we
have,
F =
[
∂Fi
∂xj
(x0)
]
and V =
[
∂Vi
∂xj
(x0)
]
where i, j = 1, ...,m and x0 is the disease free equilibrium.
The entries of FV −1 give the rate at which infected individuals in xj produce new infec-
tions in xi, multiplied by the average length of time an individual spends on a single visit
to compartment j.
Definition 2.2.1. The basic reproduction number is given by
R0 = ρ(FV −1) (2.6)
where ρ denotes the spectral radius of the matrix FV −1.
Thus, we call FV −1 the next generation matrix for the model and we shall set R0 as equal
to the spectral radius FV −1.
2.3 Stochastic Processes
Let (Ω,F ,P) be a probability space, see [60, pp9-11]. A filtration is an increasing family
{Ft}t≥0 of increasing sub-σ-algebras of F (i.e. Ft ⊂ Fs ⊂ F for all 0 ≤ t < s < ∞).
The filtration is said to be right continuous if Ft = ⋂s>tFs for all t ≥ 0. When the
probability space is complete, the filtration is said to satisfy the usual conditions if it is
right continuous and F0 contains all P -null sets.
A family {Xt}t∈I of Rd-valued random variables is called a stochastic process with param-
eter set (or index set) I and state space Rd. The parameter set I is usually the halfline
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R+ = [0,∞}, but it may also be an interval [a, b], the nonegative integers or even subsets
of Rd. Note that for each fixed t ∈ I we have a random variable
Ω 3 ω → Xt(ω) ∈ Rd.
On the other hand, for each fixed ω ∈ Ω we have a function
I 3 t→ Xt(ω) ∈ Rd
which is called a sample path of the process, and we shall write X.(ω) for the path.
Theorem 2.3.1. ([60]) If {Xt}t≥0 is a progressively measurable process and τ is a stop-
ping time, then XτII<∞ is Fτ -measurable. In particular, if τ is finite, then Xτ is {Fτ}-
measurable.
Theorem 2.3.2. ([60]) Let {Mt}t≥0 be an Rd-valued martingale with respect to {Ft}, and
let θ, ρ be two finite stopping times.
Then
E(Mθ|Fρ) = Mθ∧ρ a.s.
In particular, if τ is a stopping time, then
E(Mτ∧t|Fs) = Mτ∧s a.s.
holds for all 0 ≤ s < t < ∞. That is, the stopped process M τ = {Mτ∧t} is still a
martingale with respect to the same filtration {Ft}.
2.4 Brownian Motions
Brownian motion is the name given to the irregular movement of pollen grains, suspended
in the water, observed by the Scottish botanist Robert Brown in 1982. The motion was
later explained by the random collisions with the molecules of water. To describe the
motion mathematically it is natural to use the concept of a stochastic process Bt(ω),
interpreted as the position of the pollen grain w at time t. Let us define Brownian motion
mathematically in what follows, see for instance [60, p15]
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Definition 2.4.1. Let (Ω,F ,P) be a probability space with a filtration {Ft}t≥0. A (stan-
dard) one-dimensional Brownian motion is a real-valued continuous {Ft}-adapted process
{Bt}t≥0 with the following properties:
• B0 = 0 a.s.;
• for 0 ≤ s < t < ∞, the increment Bt − Bs is normally distributed with mean zero
and variance t− s;
• for 0 ≤ s < t <∞, the increment Bt −Bs is independent of Fs.
2.5 Itô’s Formula
Let {Bt}t≥0 be a one-dimensional Brownian motion defined on the complete probability
space (Ω,F ,P) adapted to the filtration {F}t≥0, see [60, p31]. Let L1(R+;Rd) denote the
family of all Rd-valued measurable {F}-adapted processes f = {f(t)}t≥0 such that
∫ T
0
|f(t)|dt <∞ a.s. for every T > 0.
Definition 2.5.1. A one-dimensional Itô process is a continuous adapted process x(t) on
t ≥ 0 of the form
x(t) = x(0) +
∫ t
0
f(s)ds+
∫ t
0
g(s)dBs,
where f ∈ L1(R+;R) and g ∈ L2(R+;R). We shall say that x(t) has stochastic differential
dx(t) on t ≥ 0 given by
dx(t) = f(t)dt+ g(t)dBt.
Let C2,1(Rd × R+;R) denote the family of all real-valued functions V (x, t) defined on
Rd × R+ such that they are continuously twice differentiable in x and once in t. If
V ∈ C2,1(Rd × R+;R), we set
Vt =
∂V
∂t
, Vx =
(
∂V
∂x1
, ...,
∂V
∂xd
)
,
28
http://etd.uwc.ac.za/
Vxx =
(
∂2V
∂xi∂xj
)
d×d
=

∂2V
∂x1∂x2
. . . ∂
2V
∂x1∂xd... ...
∂2V
∂x1∂x1
. . . ∂
2V
∂xd∂xd

Clearly, when V ∈ C2,1(R× R+;R), we have Vx = ∂V∂x and Vxx = ∂
2V
∂x2 .
Theorem 2.5.2. ([60]) (The one-dimensional Itô formula) Let x(t) be an Itô process on
t ≥ 0 with the stochastic differential
dx(t) = f(t)dt+ g(t)dBt,
where f ∈ L1(R+;R) and g ∈ L2(R+;R). Let V ∈ C2,1(R × R+;R). Then V (x(t), t) is
again an Itô process with the stochastic differential given by
dV (x(t), t) = [Vt(x(t), t) + Vx(x(t), t)f(t) +
1
2Vxx(x(t), t)g
2(t)]dt+ Vx(x(t), t)g(t)dBt a.s.
Theorem 2.5.3. ([60]) (The multi-dimensional Itô formula) Let x(t) be a d-dimensional
Itô process on t ≥ 0 with the stochastic differential
dx(t) = f(t)dt+ g(t)dB(t),
where f ∈ L1(R+;Rd) and g ∈ L2(R+;Rd×m). Let V ∈ C2,1(Rd×R+;R). Then V (x(t), t)
is again an Itô process with the stochastic differential given by
dV (x(t), t) = [Vt(x(t), t) + Vx(x(t), t)f(t) +
1
2trace(g
T (t)Vxx(x(t), t)g(t))]dt
+Vx(x(t), t)g(t)dB(t) a.s
Let us now introduce formally a multiplication rule:
dtdt = dBidt = 0, dBidBi = dt, dBidBj = 0 if i 6= j,
Then, for example,
dxi(t)dxj(t) =
∑
m
k=1gik(t)gjk(t)dt.
Example 2.5.4. Let us consider a real-valued function of the form g = g(S(t), I(t), J(t), A(t)).
In particular we note that ∂g
∂t
= 0. For convenience we write down the formula for the
differential of g. Applying the multi-dimensional Itô formula we obtain
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dg = ∂g
∂S
dS + ∂g
∂I
dI + ∂g
∂J
dJ + ∂g
∂A
dA+ 12
[
∂2g
∂I2
dSdS + ∂
2g
∂I2
dIdI + ∂
2g
∂J2
dJdJ
+ ∂
2g
∂A2
dAdA
]
+
[
∂2g
∂S∂I
dSdI + ∂
2g
∂S∂J
dSdJ + ∂
2g
∂S∂A
dSdA+ ∂
2g
∂I∂J
dIdJ
+ ∂
2g
∂I∂A
dIdA+ ∂
2g
∂J∂A
dJdA
]
.
2.6 Stochastic Differential equations
Consider the d-dimensional stochastic differential equation of Itô type, see [60, pp.48-51]
dx(t) = f(x(t), t)dt+ g(x(t), t)dB(t) on t0 ≤ t ≤ T (2.7)
with initial value x(t0) = x0. By the definition of stochastic differential, this equation is
equivalent to the following stochastic integral equation:
x(t) = x(0) +
∫ t
t0
f(x(s), s)ds+
∫ t
t0
g(x(s), s)dB(s) on t0 ≤ t ≤ T. (2.8)
2.7 Existence and Uniqueness of Solutions
Theorem 2.7.1. Assume that there exist two positive constants K¯ and K such that
(i) (Lipschitz condition) for all x, y ∈ Rd and t ∈ [t0, T ]
|f(x, t)− f(y, t)|2 ∧ |g(x, t)− g(y, t)|2 ≤ K¯|x− y|2; (2.9)
(ii) (Linear growth condition) for all (x, t) ∈ Rd × [t0, T ]
|f(x, t)|2 ∧ |g(x, t)|2 ≤ K(1 + |x|2). (2.10)
Then there exists a unique solution x(t) to equation (2.7) and the solution belongs to
M2([t0, T ];Rd).
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2.8 Stability of Stochastic Differential equations
Consider the d-dimensional stochastic differential equation, see for instance [60, pp.110-
128]
dx(t) = f(x(t), t)dt+ g(x(t), t)dB(t) (2.11)
on t ≥ 0 with initial value X(0) = X0, the solution is denoted by X(t,X0). Assume that
f(t, 0) = g(t, 0) = 0 for all t ≥ 0, so the origin point is an equilibrium of (2.11).
Definition 2.8.1. The equilibrium X = 0 of the system (2.11) is said to be:
(i) Stable in probability if for all  > 0,
lim
X0→0
P
(
sup
t≥0
|X(t,X0)| ≥ 
)
= 0; (2.12)
(ii) asymptotically stable if it is stable in probability and moreover;
lim
X0→0
P
(
lim
t→∞X(t,X0) = 0
)
= 1; (2.13)
(iii) globally asymptotically stable if it is stable in probability and moreover, for all X0 ∈
Rn
P
(
lim
t→∞X(t,X0) = 0
)
= 1; (2.14)
(iv) almost surely exponentially stable if for all X0 ∈ Rn,
lim
t→∞ sup
1
t
ln |X(t,X0)| < 0 a.s.; (2.15)
(v) pth moment exponentially stable if there is a pair of positive constants C1 and C2 such
that for all X0 ∈ Rn,
E (|X(t,X0|p) ≤ C1|X0|pe−C2t on t ≥ 0. (2.16)
Let us denote by L the differential operator associated to (2.11), defined for a function
V (t, x) ∈ C1,2(R× Rn) by
LV = ∂V
∂t
+ fT ∂V
∂x
+ 12Tr
[
gT
∂2V
∂x2
g
]
.
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Chapter 3
Stability of an HIV/AIDS epidemic
model with treatment and inflow of
infectives
3.1 Introduction
We investigate an HIV/AIDS epidemic model with treatment similar to that in [14].
The model allows for two stages of infection namely the asymptomatic phase and the
symptomatic phase. The ARV treatment helps the symptomatic individuals to move back
to asymptomatic phase. Thus, we only consider two stages according to clinic stages, i.e.,
the asymptomatic phase I and the symptomatic phase J . In this chapter and throughout,
we find it convenient to replace βS(I + bJ)c in [14] by S(β1I + β2J)c. We also introduce
inflow of infectives Q1 and Q2 in the model as in the diagram below:
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A J
S I
S(β1I + β2J)
k1I
k2J
αJ
(µ+ δ)A
µS
µK
µJ
µI
Q1
Q2
Figure 3.1: Flow diagram of HIV/AIDS model with inflow of infectives
We now give the description of parameters.
µ Birth and mortality rates by natural causes,
K Size of the total population,
c An individual average number of sexual contacts with others per unit time,
β1 Probability of disease transmission in the asymptomatic phase,
β2 Probability of disease transmission in the symptomatic phase,
k1 Progression rate from I to J ,
k2 Progression rate from the symptomatic phase J to A,
α Rate of transfer from J to I due to ARV treatment,
δ Disease induced mortality rate.
Our model is then constructed by considering the appropriate in-flow and out-flow rates
of each compartment as in figure (3.1) and parameters in the list above.
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dS
dt
= µk − Sλ− µS,
dI
dt
= Q1 + Sλ− (µ+ k1)I + αJ,
dJ
dt
= Q2 + k1I − (µ+ k2 + α)J,
dA
dt
= k2J − (µ+ δ)A. (3.1)
where
λ = c(β1I + β2J)
and
with S(0) = S0 > 0, I(0) = I0 ≥ 0, J(0) = J0 ≥ 0, A(0) = A0 ≥ 0
In the absence of Q1 and Q2, then the model system (3.1) permits two equilibria; the
disease-free equilibrium E0 = (K, 0, 0, 0) and the equilibrium point E∗ = (S∗, I∗, J∗, A∗).
The coordinates of the equilibrium point will be calculated at a later stage.
For calculating the basic reproduction number R0 we take Q1 = Q2 = 0. Using the next
generation matrix we re-arrange the equations so that the infective classes come first, we
obtain
dI
dt
= Sλ− (µ+ k1)I + αJ,
dJ
dt
= k1I − (µ+ k2 + α)J,
dS
dt
= µK − Sλ− µS. (3.2)
We eliminate that last compartment since it does not appear in any other compartment
and we write (3.2) by
x
′ = F (x)− V (x)
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which can also be expressed by
x
′
i = Fi − Vi or x
′
i = Fi − (V −i − V +i )
where F and V are the m× n matrices given by
F =
(
∂Fi(x0)
∂xj
)
, V=
(
∂Vi(x0)
∂xj
)
.
Then from our system we have
F=

∂Fi
∂I
∂Fi
∂J
0 0
 =
 β1Sc β2Sc
0 0

and
V=

∂V
∂I
∂V
∂J
∂V
∂I
∂V
∂J
 =

µ+ k1 −α
−k1 (µ+ k2 + α)

The derivatives of F and V at E0(0, 0, K) are given by
F=

β1cK β2cK
0 0
 and V=

(µ+ k1) −α
−k1 (µ+ k2 + α)

The inverse of V is given by
V −1 = 1(µ+k1)(µ+k2)+µα

(µ+ k2 + α) k1
α (µ+ k1)

and a calculation of FV −1 gives the basic reproductive number of the model as
ρ(FV −1) = R0 = cK ((µ+ k2 + α)β1 + β2k1)((µ+ k1)(µ+ k2) + αµ) . (3.3)
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3.1.1 Existence of the endemic equilibrium
We first compute the coordinates of the endemic equilibrium E∗ by
S∗ = µK
λ+ µ,
I∗ = α(λ+ µ)Q2 + (α + µ+ k2)(kλµ+ (λ+ µ)Q1)[(µ+ k1)(µ+ k2) + αµ](λ+ µ)
,
J∗ = 1(α + µ+ k2)
[
Q2 + k1
(
α(λ+ µ)Q2 + (α + µ+ k2)(kλµ+ (λ+ µ)Q1)
[(µ+ k1)(µ+ k2) + αµ](λ+ µ)
)]
,
A∗ = k2(µ+ δ)(α + µ+ k2)
[
Q2 + k1
(
α(λ+ µ)Q2 + (α + µ+ k2)(kλµ+ (λ+ µ)Q1)
[(µ+ k1)(µ+ k2) + αµ](λ+ µ)
)]
,
We now prove existence of the endemic equilibrium by considering λ as defined in the
model system (3.1). At the same time, λ is a root of the following polynomial
Z1λ
2 + Z2λ+ Z3 = 0; (3.4)
where
Z1 = µ(α + k2 + µ) + k1(k2 + µ)
Z2 = cβ1((−α− k2 − µ)(µK +Q1)− αQ2) + k1(µ(µ+ k2)− cβ2(µK +Q1 +Q2))
+µ(µ(α + k2)− cβ2Q2)
Z3 = −µ(cβ1(Q1(α + k2 + µ) + αQ2) + cβ2(k1(Q1 +Q2) + µQ2)).
For the case Q1 = Q2 = 0, the quadratic equation admits a root λ0 = 0 which corresponds
to the disease-free equilibrium and another root
λ1 =
µ(cβ1K(α + k2 + µ)− k1(−cβ2K + k2 + µ) + µ(α + k2 + µ))
αµ+ k1µ+ k2µ+ k1k2 + µ2
which is positive if and only if −Z2 > 0. It is also noted that a negative value of λ will
result in a point E1 which is non-feasible. Thus, if Q1, Q2 > 0 as −Z2 = h > 0 the
quadratic equation admits one positive and one negative root. The negative root is not
meaningful biologically, and so we only consider the positive root given by
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λ∗ =
−Z2 +
√
Z22 − 4Z1Z3
2Z1
.
We note that h > 0 if and only if R0 > 1, and h < 0 if and only if R0 < 1. We observe
that
lim
Q1,Q2→0
λ∗ = h+ |h|2Z1 =

0, h < 0,
h
Z1
, h > 0.
In particular it is noticed that as Q1, Q2 get closer to zero, the model has threshold
R0 = 1. Therefore, for Q1, Q2 > 0, the disease remains endemic, so the system (3.1) has
one endemic equilibrium point and the disease will remain in the population. In this case
the system (3.1) would not exhibit a disease-free equilibrium.
3.1.2 Feasible solutions
Thus, we shall study system (3.1) in the following feasible region:
∆ =
{
x ∈ R4|x1 > 0, x2 > 0, x3 > 0, x4 > 0, x1 + x2 + x3 + x4 < k
}
. (3.5)
which can be shown to be positively invariant with respect to (3.1).
3.1.3 Global stability of the disease-free equilibrium
We now prove by means of Lyapunov function that forR0 < 1 the disease-free equilibrium
E0(K, 0, 0, 0) is globally asymptotically stable if Q1 = Q2 = 0.
Let us first define the numbers pi, ξ0, ξ1, ξ2 and ξ3
37
http://etd.uwc.ac.za/
pi = (µ+ k1)(µ+ k2) + αµ,
ξ1 = β1(µ+ k2 + α) + β2k1,
ξ2 = β1α + β2(µ+ k1). (3.6)
The values of ξ0 and ξ3 will be displayed at later stage, meanwhile they are declared to
be positives.
Theorem 3.1.1. For the case Q1 = Q2 = 0, then the disease-free equilibrium E0 of
system (3.1) is globally asymptotically stable if R0 < 1.
Proof. Consider the numbers as displayed (3.6).
Assuming that R0 < 1, it is possible to find positive numbers ξ0 and ξ3 sufficiently small
such as to have the following inequality:
ξ0cβ1K + piβ1(R0 − 1) < 0, ξ0cβ2K + ξ3k2 + piβ2(R0 − 1) < 0.
Define the following function
V1(S(t), I(t), J(t), A(t)) = ξ0(K − S(t)) + ξ1I(t) + ξ2J(t) + ξ3A(t).
Differentiating V1(t), we have
V˙1(t) = −ξ0S˙(t) + ξ1 [c(β1I + β2J)S − (µ+ k1)I + αJ ] + ξ2 [k1I − (µ+ k2 + α)J ] + ξ3A˙(t)
≤ −ξ0S˙(t) + pi(R0 − 1)(β1I + β2J) + ξ3A˙(t)
= −ξ0(µ(K − S)− cK(β1I + β2J)) + pi(R0 − 1)(β1I + β2J) + ξ3(k2J − (µ+ δ)A)
= −ξ0µ(K − S) + I[ξ0cβ1K + piβ1(R0 − 1)] + J [ξ0cβ2K + ξ3k2 + piβ2(R0 − 1)]
−ξ3(µ+ δ)A. (3.7)
We note that V1 is positive-definite and V˙1 is negative-definite. Therefore the function V1
is a Lyapunov function for system (3.1) without inflow of infectives. By the Lyapunov
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asymptotic stability theorem, the disease-free equilibrium E0 is globally asymptotically
stable. This completes the proof.
3.1.4 Global stability of the endemic equilibrium
We shall now prove global stability of the endemic equilibrium.
Theorem 3.1.2. The endemic equilibrium E∗ of system (3.1) is globally asymptotically
stable for R0 > 1.
Proof. Setting r = (S, I, J) ∈ Ω ⊂ R4, we can now construct a Lyapunov function of the
form
V2 = V2(r) =
(
S − S∗ − S∗ ln S
S∗
)
+ C1
(
I − I∗ − I∗ ln I
I∗
)
+ C2
(
J − J∗ − J∗ ln J
J∗
)
(3.8)
where r∗ = E∗ = (S∗, I∗, J∗) and Ci > 0 is a constant. Thus, V2(r) ≥ 0 for r ∈ Int ∆,
and V2(r) = 0 ⇐⇒ r = r∗.
By equating each equation in system (3.1) to zero, the equilibrium equations as follows
are useful:
µK = S∗(β1I∗ + β2J∗)c+ µS∗,
(µ+ k2 + α) =
Q2
J∗
+ k1
I∗
J∗
,
(µ+ k1) =
Q1
I∗
+ S
∗(β1I∗ + β2J∗)c
I∗
+ αJ
∗
I∗
.
(3.9)
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The time derivative of V2 is
V˙2 = S˙
(
1− S
∗
S
)
+ C1I˙
(
1− I
∗
I
)
+ C2J˙
(
1− J
∗
J
)
. (3.10)
We substitute (3.9) into (3.10)
V˙2 =
(
1− S
∗
S
)
(−cS(β1I + β2J)− µS + cS∗(β1I∗ + β2J∗) + µS∗)
+C1
(
1− I
∗
I
)
(Q1 + S(β1I + β2J)c+ αJ
−(Q1 + β1S
∗cI∗ + β2S∗cJ∗ + αJ∗)I
I∗
)
+C2
(
1− J
∗
J
)(
Q2 + k1I −
(
Q2
J∗
+ k1
I∗
J∗
))
. (3.11)
Expanding and grouping some terms we have
V˙2 = µS∗
(
2− S
S∗
− S
∗
S
)
+
(
1− S
∗
S
)
cβ1(I∗S∗ − IS)
+
(
1− S
∗
S
)
cβ1(J∗S∗ − JS) + C1
(
1− I
∗
I
)(
Q1 −Q1 I
I∗
)
+C1
(
1− I
∗
I
)
β1c
(
IS − I∗S∗ I
I∗
)
+C1
(
1− I
∗
I
)
β2c
(
JS − J∗S∗ I
I∗
)
+ C1α
(
1− I
∗
I
)(
J − J∗ I
I∗
)
+C2k1
(
1− J
∗
J
)(
I − I∗ J
J∗
)
+ C2
(
1− J
∗
J
)(
Q2 −Q2 J
J∗
)
. (3.12)
Let
S
S∗
= x, I
I∗
= y, J
J∗
= z.
Then (3.12) becomes
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V˙2 = µS∗
(
2− 1
x
− x
)
+ cβ1I∗S∗
(
1− xy − 1
x
+ y
)
+cβ2J∗S∗
(
1− xz − 1
x
+ z
)
+ C1
(
2− 1
y
− y
)
Q1
+C1β1cS∗I∗(xy − y − x+ 1) + C1β2cS∗J∗
(
xz − xz
y
− y + 1
)
+C1αJ∗
(
z − y − z
y
+ 1
)
+ C2k1I∗
(
y − z − y
z
+ 1
)
+C2
(
2− 1
z
− z
)
Q2. (3.13)
Expanding further we have
V˙2 = µS∗
(
2− 1
x
− x
)
+ C1
(
2− 1
y
− y
)
Q1 + cβ1I∗S∗ − cβI∗S∗xy − cβI∗S∗ 1
x
+cβ1I∗S∗y + cβ2J∗S∗ − cβ2J∗S∗xz − cβ2J∗S∗ 1
x
+ cβ2J∗S∗z
+C1β1cS∗I∗xy − C1β1cS∗I∗y − C1β1cS∗I∗x+ C1β1cS∗I∗ + C1β2cS∗J∗xz
−C1β2cS∗J∗xz
y
− C1β2cS∗J∗y + C1β2cS∗J∗
+C1αJ∗z − C1αJ∗y − C1αJ∗ z
y
+ C1αJ∗ + C2k1I∗y − C2k1I∗z
−C2k1I∗y
z
+ C2k1I∗. (3.14)
Grouping some terms like xy, xz, y and z, then we have
V˙2 = µS∗
(
2− 1
x
− x
)
+ C1
(
2− 1
y
− y
)
Q1 + cβ1I∗S∗xy(C1 − 1) + cβ2J∗S∗xz(C1 − 1)
+y(cβ1S∗I∗ − C1cβ1S∗I∗ − C1cβ2S∗J∗ − C1αJ∗ + C2k1I∗)
+z(cβ2S∗J∗ + C1αJ∗ − C2k1I∗) + cβ1I∗S∗ − cβ1I∗S∗ 1
x
+cβ2J∗S∗ − cβ2J∗S∗ 1
x
+ C1β1cS∗I∗ − C1β2cS∗J∗xz
y
+ C1β2cS∗J∗
−C1αJ∗ z
y
+ C1αJ∗ − C2k1I∗y
z
+ C2k1I∗ − C1β1cS∗I∗x (3.15)
We choose the coefficients of xy, xz, y and z which are equal to zero; that is,
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(C1 − 1) = 0,
cβ1S
∗I∗ − C1cβ1S∗I∗ − C1cβ2S∗J∗ − C1αJ∗ + C2k1I∗ = 0,
cβ2S
∗J∗ + C1αJ∗ − C2k1I∗ = 0.
Thus we have
C1 = 1, C2 =
cβ2S
∗J∗ + αJ∗
k1I∗
.
Equation (3.15) is reduced to the following.
V˙2 = µS∗
(
2− 1
x
− x
)
+ C1
(
2− 1
y
− y
)
Q1 + cβ1S∗I∗
(
2− 1
x
− x
)
+cβ2S∗J∗
(
2− 1
x
− xz
y
)
− z
y
αJ∗ + αJ∗ − y
z
C2k1I
∗
+C2k1I∗ + C2
(
2− 1
z
− z
)
Q2. (3.16)
By substituting C1, C2 in (3.16) it follows that
V˙2 = S∗(µ+ cβ1I∗)
(
2− 1
x
− x
)
+
(
2− 1
y
− y
)
Q1 + cβ2S∗J∗
(
3− 1
x
− xz
y
− y
z
)
+αJ∗
(
2− z
y
− y
z
)
+ C2
(
2− 1
z
− z
)
Q2. (3.17)
Note that since the arithmetical mean is greater than or equal to the geometric mean,
that is
(a1 + a2 + ...+ an)/n ≥ n√a1a2...an for ai ≥ 0, i = 1, .., n,
then it follows that (2− x− 1/x) ≤ 0 for x > 0 and (2− x− 1/x) = 0 if and only if x = 1;
(2− y − 1/y) ≤ 0 for y > 0 and (2− y − 1/y) = 0 if and only if y = 1; (2− z − 1/z) ≤ 0
for z > 0 and (2− z − 1/z) = 0 if and only if z = 1;
(
2− z
y
− y
z
)
≤ 0 for y, z > 0 and(
2− z
y
− y
z
)
= 0 if and only if y = z;
(
3− 1
x
− xz
y
− y
z
)
≤ 0 for x > 0, y > 0, and z > 0
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and
(
3− 1
x
− xz
y
− y
z
)
= 0 if and only if x = y = z = 1. Therefore, it is easy to see that
V˙2 ≤ 0. Furthermore, V˙2 = 0 if and only if x = y = z = 1. The maximum invariant set of
system (3.1) on the set {(x, y, z) : V˙ = 0} is the singleton (1, 1, 1). Thus, for system (3.1),
the endemic equilibrium E∗ is globally asymptotically stable if R0 > 1 by the Lasalle
invariance principle. 2
3.2 Numerical simulations and concluding remarks
We present some numerical simulations in the general context to investigate the dynamics
of the model system with and without the inflow of infectives. For some numerical simu-
lations in the context of the South African HIV historical data, we let the reader refer to
chapters 5, 6, 7 and 8. The parameter values of the model are given in the table below.
Table 3.1: Estimating parameters for model system 3.1
Parameter Estimated values Ref
µ 0.017 [7]
µ0 0.017 [7]
α 0.21 [7]
k1 0.3 Estimated
k2 0.3 Estimated
c 3 [7]
δ 0.21 Estimated
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Figure 3.2: The population dynamics with and without inflow
In Figure 3.2, we show the population dynamics of HIV/AIDS with and without positive
flow of infectives. It can be seen that whenever there is positive inflow of infectives, then
the model system (3.1) does not permit a disease-free equilibrium even when R0 < 1,
see for example in Figure 3.2 (c). In Figure 3.2 (b) and (d), we show that the presence
of the inflow of infectives makes the disease to stabilize more at the endemic level. The
basic reproduction number in (d) is less than in (b), but the graph in Figure (d) is more
endemic than in Figure (b).
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Chapter 4
Stochastic dynamics of an
HIV/AIDS epidemic model with
treatment1
4.1 Introduction
In this chapter, we investigate a stochastic HIV/AIDS epidemic model with treatment.
The model allows for two stages of infection namely the asymptomatic phase and the
symptomatic phase. We prove existence of global positive solutions. We show that the
solutions are stochastically ultimately bounded and stochastically permanent. We also
study asymptotic behaviour of the solution to the stochastic model around the disease-free
equilibrium of the underlying deterministic model. Our theoretical results are illustrated
by way of numerical simulations.
Examples of stochastic models for HIV/AIDS can be found in [113, 26, 47]. In [26], the
authors study a model of AIDS and condom use via the technique of parameter perturba-
1A modified version of this chapter was published as:
M.U. Nsuami, P.J. Witbooi. Stochastic dynamics of an HIV/AIDS epidemic model with treatment.
Quaestiones Mathematicae, (2018) 1-17.
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tion which is standard in stochastic population modeling. Their research indicates that
introducing environmental noise into the deterministic model can have a stabilising effect.
The paper by Yang et al. [113] investigates the dynamic behaviour of an HIV model with
stochastic perturbation and the authors obtain the asymptotic behaviour results. Kamina
et al. [47] models the population dynamics of the human immunodeficiency virus type-1
(HIV-1) population dynamics with the use of diffusion processes. The authors incorporate
more of the randomness of the HIV-1 infection process to investigate the probability and
the possibility of viral extinction in their model.
The chapter is structured as follows. In Section 4.2 we give some preliminaries. In Section
4.3 we present the model and we show the existence of global solutions. In Section
4.4 we study the ultimate boundedness and stochastic permanence properties. Section
4.5 studies asymptotic behaviour around the disease-free equilibrium of the underlying
deterministic model. Section 4.6 gives a numerical illustrations and Section 4.7 provides
some concluding remarks.
4.2 Preliminaries
Let us denote by Rn+ (resp. Rn++) the set of points in Rn having only non-negative (resp.
strictly positive) coordinates.
Throughout this paper we assume a complete probability space (Ω,F ,P) with a filtration,
{Ft}t≥0, that is right continuous and with F0 containing all the subsets having measure
zero.
Consider an equation of the form (4.1) below, for an k-dimensional Brownian motion B(t)
on Ω.
dx(t) = f(t, x)dt+ g(t, x)dB(t) (4.1)
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A solution with initial value x(0) = x0 is denoted by x(t, x0). Assume that f(t, 0) =
g(t, 0) = 0 for all t ≥ 0, so the origin point is an equilibrium of (4.1).
For a stochastic process x(t) which is a function of B(t), when we wish to single out a
specific Brownian path ω, we shall write x(t, ω).
By L we denote the infinitesimal generator of an equation of the form (4.1), see [72] of
∅ksendal, defined for a function V (t, x) ∈ C1,2(R+ × Rk).
Definition 4.2.1. (see [51, 115]) A solution x(t) of the system (4.1) is said to be stochas-
tically ultimately bounded if for any  ∈ (0, 1), there is a positive constant ϕ = ϕ(), such
that for any positive initial value x(0),
lim sup
t→∞
P{|x(t)| > ϕ} ≤ .
Definition 4.2.2. (see [77]) A solution x(t) of system (4.1) is said to be stochastically
permanent if for any  ∈ (0, 1), there exists a pair of positive constants ϕ = ϕ() and
ξ = ξ(), such that for any positive initial value x(0), the following condition holds:
lim inf
t→∞ P {|x(t)| ≤ ϕ} ≥ 1− , and lim inft→∞ P {|x(t)| ≥ ξ} ≥ 1− .
Remark 4.2.3. The following inequality will be useful in Sections 4 and 5.
Given any finite sequence of real numbers u1, u2, ... , un, then
(
n∑
i=1
ui)2 ≤ n(
n∑
i=1
u2i ). (4.2)
4.3 The model and global solutions
In the underlying deterministic model, we assume a total population which at any time
t is subdivided into four classes. The classes are: the class of susceptible individuals
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S(t), the class of asymptomatic individuals I(t), the class of symptomatic individuals
J(t) and the class of the population who have full-blown AIDS A(t). The term µK is the
recruitment rate into the population, µ being the birth rate which is assumed to coincide
with the average mortality rate by natural causes. The disease-induced mortality rate is
denoted by δ. The parameters β1, β2 denote the probabilities of disease transmission per
contact by an infective in the first and second stage respectively. For an individual, c is
the average number of contacts with others per unit time. By k1 and k2 we denote the
transfer rates from the asymptomatic phase I to the symptomatic phase J and from the
symptomatic phase to the A-class, respectively. The parameter α is the rate of transfer
from the symptomatic phase J to the asymptomatic phase I due to treatment.
Let W (t) = (W0(t),W1(t),W2(t),W3(t)) be a 4-dimensional Wiener process defined on
this probability space. The components of W are assumed to be mutually independent.
In the model below, the non-negative constants σ0, σ1, σ2 and σ3 denote the intensities of
the stochastic perturbations.
In the literature, it is showed that there are different possible approaches to introduce
random effects in the epidemic models affected by environmental white noise from biologi-
cal significance and mathematical perspective. Here, we mainly mention three approaches
to the model (3.1) as an example. For the first model, we assume that white noise type
stochastic perturbations are directly proportional to S, I, J, A influenced on the dS, dI, dJ
and dA in the model (3.1) with or without the positive inflow of infected individuals. The
model takes the following form.
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dS = [µK − c(β1I + β2J)S − µS] dt+ σ0SdW0(t),
dI = [c(β1I + β2J)S − (µ+ k1)I + αJ ] dt+ σ1IdW1(t),
dJ = [k1I − (µ+ k2 + α)J ] dt+ σ2JdW2(t),
dA = [k2J − (µ+ δ)A] dt+ σ3AdW3(t). (4.3)
The second one, because system (3.1) has a positive equilibrium E∗ = (S∗, I∗, J∗, A∗) un-
derR0 > 1, we can introduce stochastic perturbations which are linked to S(t), I(t), J(t), A(t)
from values of S∗, I∗, J∗, A∗, respectively. In detail, that is,
dS = [µK − c(β1I + β2J)S − µS] dt+ σ0(S − S∗)dW0(t),
dI = [c(β1I + β2J)S − (µ+ k1)I + αJ ] dt+ σ1(I − I∗)dW1(t),
dJ = [k1I − (µ+ k2 + α)J ] dt+ σ2(J − J∗)dW2(t),
dA = [k2J − (µ+ δ)A] dt+ σ3(A− A∗)dW3(t). (4.4)
As a third approach, one can add randomly fluctuation affecting directly the deterministic
model. Suppose that infection rate β1 and β2 are stochastically perturbed with
β1 → β1 + σ0B˙(t), β2 → β2 + σ0B˙(t), namely
dS = [µK − c(β1I + β2J)S − µS] dt− σ0cβ1ISdW0(t)− σ1cβ2JSdW0(t),
dI = [c(β1I + β2J)S − (µ+ k1)I + αJ ] dt− σ0cβ1ISdW0(t)− σ1cβ2JSdW0(t),
dJ = [k1I − (µ+ k2 + α)J ] dt
dA = [k2J − (µ+ δ)A] dt (4.5)
Let us consider the model (4.3).
In the special case when σ0 = 0, the model system (4.3) permits a disease-free equilibrium
E0 = (K, 0, 0, 0). The basic reproduction number of the underlying deterministic model
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is very similar to the one in [14] and is computed as
R0 = cK[β1(µ+ k2 + α) + β2k1](µ+ k1)(µ+ k2) + αµ .
We use the notation:
X(t) = (S(t), I(t), J(t), A(t)).
In what follows we show that solutions of (4.3) exist globally and are positive (a.s), see
for instance [77, 115].
Theorem 4.3.1. For model (4.3) and any initial value (S(0), I(0), J(0), A(0)) ∈ R4++,
there is a unique solution (S(t), I(t), J(t), A(t)) on t ≥ 0 which remains in R4++ with
probability one.
Proof. Note that the coefficients of the system (4.3) are locally Lipschitz continuous. Thus
there exists a unique local solution on t ∈ [0, τe), where τe is the explosion time. We need
to show that this solution is global almost surely (a.s) ; that is, τe =∞ a.s.
Let m0 > 0 be sufficiently large so that S(0), I(0), J(0), and A(0) sits within the interval
[1/m0,m0]. For each integer m ≥ m0, define a sequence of stopping times by
τm = inf
{
t ∈ [0, τe) : S(t) /∈
( 1
m
,m
)
or I(t) /∈
( 1
m
,m
)
or J(t) /∈
( 1
m
,m
)
or A(t) /∈
( 1
m
,m
)}
where we set inf∅ = ∞. Now since the sequence (τm) is non-decreasing, the following
limit exists:
τ∞ = lim
m→∞ τm,
and τ∞ ≤ τe (a.s.). Now we need to show τ∞ =∞ a.s. If this statement is violated, then
there exist T > 0 and  ∈ (0, 1) such that
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P{τ∞ ≤ T} > . (4.6)
Thus, there is an integer m1 ≥ m0 such that
P{τm ≤ T} ≥  ∀m ≥ m1. (4.7)
Choose a0 > 0 sufficiently small in order to have a0cβ1 < µ and a0cβ2 < µ. Consider the
function V1 defined by
V1(S, I, J, A) =
(
S − a0 − a0 ln S
a0
)
+
(
I − 1− ln I
)
+
(
J − 1− ln J
)
+
(
A− 1− lnA
)
.
Note that each of the four bracketed terms are non-negative while (S(t), I(t), J(t), A(t)) ∈
R4++. By applying Itô’s formula we have,
dV1(S, I, J, A) = LV1dt+ (S − a0)σ0dW0(t) + (I − 1)σ1dW1(t)
+(J − 1)σ2dW2(t) + (A− 1)σ3dW3(t), (4.8)
where
LV1 =
[(
1− a0
S
)(
µK − c(β1I + β2J)S − µS
)]
+
[(
1− 1
I
)(
c(β1I + β2J)S
−(µ+ k1)I + αJ)
)]
+
[(
1− 1
J
)(
k1I − (µ+ k2 + α)J
)]
+
[(
1− 1
A
)(
k2J − (µ+ δ)A
)]
+ 12(a0σ
2
0 + σ21 + σ22 + σ23)
≤ µK − µ(I + J) + a0c(β1I + β2J) + µ(3 + a0) + k1 + k2 + α + δ
+12
(
a0σ
2
0 + σ21 + σ22 + σ23).
Note that by the choice of a0 we have:
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a0cβ1I − µI = I (a0cβ1 − µ) < 0 and a0cβ2J − µJ = J (a0cβ2 − µ) < 0.
Therefore
LV1 ≤ C,
where C = µK + µ(3 + a0) + k1 + k2 + α + δ + 12 (a0σ
2
0 + σ21 + σ22 + σ23) is a constant.
Integrating both sides of (4.8) from 0 to τm ∧ T yields
∫ τm∧T
0
dV1(S(s), I(s), J(s), A(s)) ≤
∫ τm∧T
0
Cds+H(τm ∧ T ),
where
H(s) =
∫ s
0
(S(u)− a0)σ0dW0(u) +
∫ s
0
(I(u)− 1)σ1dW1(u) +
∫ s
0
(J(u)− 1)σ2dW2(u)
+
∫ s
0
(A(u)− 1)σ3dW3(u).
Note that H(s) is a mean zero martingale process. Thus by taking expectations we have
E
[
V1(S(τm ∧ T ), I(τm ∧ T ), I(τm ∧ T ), J(τm ∧ T ))
]
≤ V1(S(0), I(0), J(0), A(0)) + CT.
Set Ωm = {τm ≤ T} for m ≥ m1. From equation (4.7), we have that P(Ωm) ≥  for each
m > m1. For every ν ∈ Ωm, we have
{S(τm, ν), I(τm, ν), J(τm, ν), A(τm, ν)}
⋂ {m, 1/m} 6= ∅.
Consequently, for every ν ∈ Ωm
V1(S(τm ∧ T ), I(τm ∧ T ), J(τm ∧ T ), A(τm ∧ T )) ≥ Dm
where
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Dm = min
u∈{1,a0}
{
m− u− u ln m
u
,
1
m
− u− u ln 1
um
}
> 0.
Then we obtain
V1(S(0), I(0), J(0), A(0)) + CT
≥ E
[
(1ΩmV1(S(τm ∧ T ), I(τm ∧ T ), J(τm ∧ T ), A(τm ∧ T ))
]
≥ Dm,
where 1Ωm is the indicator function of Ωm. Letting m → ∞ leads to the contradiction
∞ = V1(S(0), I(0), J(0), A(0)) + CT < ∞. Therefore, the solution of model (4.3) is
positive and will not explode in finite time, with probability one. This completes the
proof.
The solution X(t) of model system (4.3) is stochastically ultimately bounded and stochas-
tically permanent.
4.4 Ultimate boundedness and permanence
The solutions to system (4.3) are expected to exhibit some further properties, other than
positivity. In this section we investigate for stochastically ultimate boundedness and
stochastic permanence.
Theorem 4.4.1. For any initial value X(0) in R4++, system (4.3) is stochastically ulti-
mately bounded.
Proof. Let m0 > 0 be sufficiently large such that every coordinate of X(0) is contained
within the interval ( 1
m0
,m0). For each integer k ≥ m0, define the stopping time
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τk = inf
{
t ≥ 0 : S(t) /∈
(1
k
, k
)
or I(t) /∈
(1
k
, k
)
or J(t) /∈
(1
k
, k
)
or A(t) /∈
(1
k
, k
)}
. (4.9)
By Theorem 4.3.1, τk →∞ almost surely as k →∞. We have
dN = d(S + I + J + A)
= (µK − µN − δA)dt+ σ0SdW0(t) + σ1IdW1(t)
+σ2JdW2(t) + σ3AdW3(t).
Applying Itoˆ’s formula to eµtN gives
deµtN = µeµtNdt+ eµtdN
= (µeµtK − eµtδA)dt+ σ0eµtSdW0(t) + σ1eµtIdW1(t)
+σ2eµtJdW2(t) + σ3eµtAdW3(t).
≤ µeµtKdt+ σ0eµtSdW0(t) + σ1eµtIdW1(t)
+σ2eµtJdW2(t) + σ3eµtAdW3(t) (4.10)
By integrating this inequality and then taking expectations on both sides of (4.10), one
can see that
E
[
eµ(t∧τk)N(t ∧ τk)
]
−N(0) ≤ E
[∫ t∧τk
0
µeµsKds
]
≤ K(eµt − 1).
Letting k →∞ we obtain the inequality
eµtE[N(t)]−N(0) ≤ K(eµt − 1).
Consequently,
lim sup
t→∞
E[N(t)] ≤ K.
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Note that |X| = √S2 + I2 + J2 + A2 ≤ N, and therefore
lim sup
t→∞
E[|X(t)|] ≤ K.
Now for any given  > 0, let us write ϕ = K/. We complete the proof by using Markov’s
inequality, obtaining
lim sup
t→∞
P{|X(t)| > ϕ} ≤ lim sup
t→∞
E[|X(t)|]
ϕ
≤ K
ϕ
= .
The property of permanence is quite a significant property since it refers to the long term
boundedness of |X(t)| as well as boundedness away from zero in the long term.
Lemma 4.4.2. Assume that there exist positive constants ρ and h satisfying:
h
ρ
+ µ+ δ + ρ+ 12 max{σ
2
0, σ
2
1, σ
2
2, σ
2
3} < µK. (4.11)
For any initial value X(0) ∈ R4++, the solution X(t) satisfies the inequality
lim sup
t→∞
E
[
1
|X(t)|ρ
]
≤ 2ρH,
where
H =
(
C22
4hC1
+ 1
)
max
{
1, (1 + v#)ρ−2
}
,
v# =
C2 +
√
C22 + 4C1h
2C1
and
C1 = ρ
(
µK − µ− δ − ρ+ 12 max{σ
2
0, σ
2
1, σ
2
2, σ
2
3}
)
− h,
C2 = ρ
(
µ+ δ + max{σ20, σ21, σ22, σ23}
)
+ 2h. (4.12)
55
http://etd.uwc.ac.za/
Proof. Let us assume existence of ρ and h to satisfy condition (4.11). Now we define the
function V2(S, I, J, A) = (S+ I +J +A)−1 for X(t) ∈ R4++. Applying the Itô formula, we
have
L[(1 + V2)ρ] = ρ(1 + V2)ρ−2Γ,
where
Γ =
[1
2(ρ− 1)V
4
2 + (1 + V2)V 32
]
(σ20S2 + σ21I2 + σ22J2 + σ23A2)
−(1 + V2)V 22 (µK − µN − δA) .
Note that
1
2(ρ− 1)V
4
2 + (1 + V2)V 32 =
1
2(ρ+ 1)V
4
2 + V 32 .
Using the identity V2N = 1 together with the inequalities V2A < 1 and
V 22
(
σ20S
2 + σ21I2 + σ22J2 + σ23A2
)
< max
{
σ20, σ
2
1, σ
2
2, σ
2
3
}
,
we obtain an inequality as follows
Γ ≤
[1
2(ρ+ 1)V
2
2 max
{
σ20, σ
2
1, σ
2
2, σ
2
3
}
+ V2max
{
σ20, σ
2
1, σ
2
2, σ
2
3
} ]
−V 22 (µK − µ− δ) + V2(µ+ δ)− V 32 µK .
On the right hand side of the latter inequality, we drop the negative term −V 32 µK and
we reshuffle terms to obtain
Γ ≤ −V 22
(
µK − (µ+ δ)− ρ+ 12 max
{
σ20, σ
2
1, σ
2
2, σ
2
3
} )
+V2
(
µ+ δ + max{σ20, σ21, σ22, σ23}
)
.
In fact we can now express Γ in the inequality below, with C1 and C2 are as defined in
(4.12):
Γ ≤ −V 22
(C1 + h
ρ
)
+ V2
(C2 − 2h
ρ
)
.
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Again by the Itô formula we have
L[eht(1 + V2)ρ] = heht(1 + V2)ρ + ehtL(1 + V2)ρ
= eht(1 + V2)ρ−2(h(1 + V2)2 + ρΓ)
≤ eht(1 + V2)ρ−2(−C1V 22 + C2V2 + h) .
Recall that v# = (C2 +
√
C22 + 4C1h)/(2C1). If V2 > v#, then L(eht(1 + V2)ρ) ≤ 0.
Now note that eht(1 + V2)ρ−2 is positive. So in order to find an upper bound for the
right hand side of the inequality above, it suffices to maximize the factors separately. We
continue on this to find that
−C1V 22 + C2V2 + h ≤
C22
4C1
+ h,
and over 0 < V2 ≤ v# we get
(1 + V2)ρ−2 ≤ max{1, (1 + v#)ρ−2}.
Therefore,
L(eht(1 + V2)ρ) ≤ eht
(
max{1, (1 + v#)ρ−2}
)( C22
4C1
+ h
)
= ehthH.
Thus it can be deduced that
E
[
eht(1 + V2(t))ρ
]
≤ eht(1 + V2(0))ρ + hH e
ht
h
.
Therefore
lim sup
t→∞
E
[
V2(t)ρ
]
≤ lim sup
t→∞
E
[
(1 + V2(t))ρ
]
≤ H.
For (S, I, J, A) ∈ R4++, from the inequality (4.2) it follows that
S + I + J + A ≤
√
4(S2 + I2 + J2 + A2).
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Consequently, for any ρ > 0,
(S + I + J + A)ρ ≤ 2ρ(S2 + I2 + J2 + A2) ρ2 = 2ρ |X|ρ .
Taking reciprocals the latter inequality yields
1
|X|ρ ≤
2ρ
(S + I + J + A)ρ .
Therefore we can conclude that
lim sup
t→∞
E
[
1
|X(t)|ρ
]
≤ 2ρ lim sup
t→∞
E[(V2(t))ρ] ≤ 2ρH,
which completes the proof. 2
We can now prove the stochastic permanence.
Theorem 4.4.3. If max{σ20, σ21, σ22, σ23} < 2(µK− (µ+ δ)), then the solution of the model
(4.3) is stochastically permanent.
Proof. By Theorem 4.4.1, we have P{|X(t)| > ϕ} ≤ . This implies
P{|X(t)| ≤ ϕ} ≥ 1− ,
from which it follows that
lim inf
t→∞ P{|X(t)| ≤ ϕ} ≥ 1− .
The assumption max{σ20, σ21, σ22, σ23} < 2(µK − (µ + δ)) implies that there exists ρ > 0
such that
µ+ δ + ρ+ 12 max{σ
2
0, σ
2
1, σ
2
2, σ
2
3} < µK
and given the latter inequality, there exists h > 0 such that
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hρ
+ µ+ δ + ρ+ 12 max{σ
2
0, σ
2
1, σ
2
2, σ
2
3} < µK.
Therefore Lemma 4.4.2 applies, and so it follows that for H as in Lemma 4.4.2:
lim sup
t→∞
E
[
1
|X(t)|ρ
]
≤ 2ρH.
Now, for any  > 0, let ξ = 12
(

H
) 1
ρ . Then
P{|X(t)| < ξ} = P
{
1
|X(t)| >
1
ξ
}
= P
{
ξ
|X(t)| > 1
}
= P
{(
ξ
|X(t)|
)ρ
> 1
}
≤ ξρE
[
1
|X(t)|ρ
]
Hence,
lim sup
t→∞
P{|X(t)| < ξ} ≤ ξρ(2ρH) = ,
from which it follows that
lim inf
t→∞ P{|X(t)| ≥ ξ} ≥ 1− .
The proof is complete.
4.5 Asymptotic behaviour around the disease-free
equilibrium of the underlying deterministic model
In the deterministic models, the biological significance of the asymptotic stability of the
disease-free equilibrium state is that the disease will go extinct, while the stability of
the endemic equilibrium state means that the disease will persist in a given population.
However, it can be seen that the model system (4.3) has no equilibrium states and that
is why we study the asymptotic behaviour around the equilibrium of the underlying de-
terministic system.
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Before stating the main theorem of this section, let us first define the following numbers:
pi = (µ+ k1)(µ+ k2) + αµ, b4 = β2pi
(1−R0)
k2
,
b5 = β1pi
(1−R0)
2k1
, b1 =
b2
2K , b2 = β1(µ+ k2 + α) + β2k1,
b3 = β2(µ+ k1) + β1α + b5. (4.13)
Theorem 4.5.1. Suppose that the following conditions are satisfied:
R0 < 1, σ20 < µ.
Then for any given initial value (S(0), I(0), J(0), A(0)) ∈ R4++, the solution of the model
(3.1) has the property:
lim sup
t→∞
1
t
E
∫ t
0
[
(S(τ)−K)2 + I(τ) + J(τ) + A(τ)
]
dτ ≤ 2b1σ20
K2
θ
,
where
θ = min
{
2(µ− σ20), pi
(1−R0)
2 β1, b4(µ+ δ), b5(µ+ k2 + α)
}
.
Proof. Set Q = S −K. Then the system 4.3 can be written as
dQ = [−µQ− c(β1I + β2J)(K +Q)] dt+ σ0(K +Q)dW0(t)
dI = [c(β1I + β2J)(K +Q)− (µ+ k1)I + αJ ] dt+ σ1IdW1(t),
dJ = [k1I − (µ+ k2 + α)J ] dt+ σ2JdW2(t),
dA = [k2J − (µ+ δ)A] dt+ σ3AdW3(t).
For the numbers bi as in display (4.13) above, consider the following positive-definite
function:
V3(Q, I, J, A) = b1Q2 + b2I + b3J + b4A.
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Then ∫ t
0
dV3(Q, I, J, A) =
∫ t
0
LV3(Q, I, J, A)du+Mt
where
Mt =
∫ t
0
2b1Qσ0(K +Q)dW0(u) +
∫ t
0
b2σ1IdW1(u)
+
∫ t
0
b3σ2JdW2(u) +
∫ t
0
b4σ3AdW3(u)
and
LV3(Q, I, J, A) = 2b1Q[−µQ− c(β1I + β2J)(K +Q)] + b1[σ20(K +Q)2]
+b2[c(β1I + β2J)(K +Q)− (µ+ k1)I + αJ ]
+b3[k1I − (µ+ k2 + α)J ] + b4[k2J − (µ+ δ)A].
We simplify and reorganize the terms to get
LV3 = −2b1µQ2 + b1[σ20(K +Q)2] + Y1 + Y2 − b4(µ+ δ)A (4.14)
where Y1 and Y2 are given by:
Y1 = −2b1c(β1I + β2J)Q(K +Q) + b2c(β1I + β2J)(K +Q)
Y2 = b2[−(µ+ k1)I + αJ ] + b3[k1I − (µ+ k2 + α)J ] + b4k2J.
Following the inequality (4.2), regarding the second term in equation (4.14) we get
b1σ
2
0[K +Q]2 ≤ 2b1σ20(K2 +Q2).
The term Y1 can be expanded as
Y1 = −2b1c(β1I + β2J)Q2 + c(β1I + β2J)Q(b2 − 2Kb1) + b2c(β1I + β2J)K.
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Noting that b2 = 2Kb1, we obtain the inequality
Y1 ≤ b2c(β1I + β2J)K.
A routine calculation reveals that
b2c(β1I + β2J)K + Y2 = pi
(R0 − 1)
2 β1I − b5(µ+ k2 + α)J.
Thus we obtain the following inequality:
LV3 ≤ −2b1(µ− σ20)Q2 + pi
(R0 − 1)
2 β1I − b4(µ+ δ)A
−b5(µ+ k2 + α)J + 2b1σ20K2.
Therefore ∫ t
0
dV3 ≤
∫ t
0
[
− 2b1(µ− σ20)Q2 − pi
(1−R0)
2 β1I
−b5(µ+ k2 + α)J − b4(µ+ δ)A+ 2b1σ20K2
]
du+Mt.
We take expectation and note that E[Mt] = 0. Thus we obtain
0 ≤ E
[
V3(Q(t), I(t), J(t), A(t))
]
≤ E
[
V3(Q(0), I(0), J(0), A(0))
]
+ E
[ ∫ t
0
{
− 2b1(µ− σ20)(Q(u))2 − pi
(1−R0)
2 β1I(u)
−b5(µ+ k2 + α)J(u)− b4(µ+ δ)A(u) + 2b1σ20K2
}
du
]
which gives
E
[ ∫ t
0
{
2b1(µ− σ20)(Q(u))2 + pi
(1−R0)
2 β1I(u) + b5(µ+ k2 + α)J(u) + b4(µ+ δ)A(u)
}
du
]
≤ E[V3(Q(0), I(0), J(0), A(0))] + 2b1σ20K2t.
Therefore,
lim sup
t→∞
1
t
E
[ ∫ t
0
{
2b1(µ−σ20)(Q(u))2+pi
(1−R0)
2 β1I(u)+b5(µ+k2+α)J(u)+b4(µ+δ)A(u)
}
du
]
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≤ 2b1σ20K2.
We take θ as in the formulation of the theorem, and then it follows that:
lim sup
t→∞
1
t
E
[ ∫ t
0
{
(S(τ)−K)2 + I(τ) + J(τ) + A(τ)
}
dτ
]
≤ 2b1σ20
K2
θ
.
The proof is complete.
Remark 4.5.2. Theorem 4.5.1 asserts that under the given conditions if the stochas-
tic perturbations are small, then in the long term the sample paths of a solution of the
stochastic system (4.3) will tend to stay within a certain neighbourhood of the disease-free
equilibrium of the deterministic model.
4.6 Simulations
We present some numerical simulations in order to illustrate the analytical results of
stochastic model (4.3). Regarding the parameters we note the following. The parameters
have been chosen so as to be applicable to Southern Africa, mostly taken from [9]. We
expect to see a value of β2 significantly bigger than β1, since the more advanced the
infection has become, the probability of disease transmission in the symptomatic phase
exceeds that of the asymptomatic phase. In [40], the parameter c is assigned values
ranging from 1 to 2 for the average number of sexual partners per given time. In our case
we take c = 3 in order to avoid addressing a problem that is simpler than the actual one.
The value of K is the size of the population and does not have an effect on the relative
sizes of the different classes. Consequently we regard K as nominal. In order to illustrate
the results, we vary the values of β1 and β2. The parameter values of the model are given
in the table below.
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Table 4.1: Description of parameters and their values for model system 3.1
Parameters Value Source
µ 0.02 [9]
α 0.33 [9]
k1 0.125 [41]
k2 0.1 [9]
c 3 cf. [40]
δ 0.333 [9]
K 6.5 Nominal
with the initial conditions: S0 = 4.5, I0 = 1, J0 = 0.6, A0 = 0.4. In each graph we
show four trajectories, the S-class and the J=class of the stochastic model (one sample
path) and of the underlying deterministic model.
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Figure 4.1: A case with R0 > 1 and R0 = 2.938838313
Chosen Values:
β1 = 0.002; β2 = 0.005;σ0 = 0.001;σ1 = 0.05;σ2 = 0.05;σ3 = 0.05;R0 = 2.938838313.
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Figure 4.2: Theorem 4.5.1 guarantees stability in the mean.
Chosen Values:
β1 = 0.00067; β2 = 0.001675;σ0 = 0.01;σ1 = 0.1;σ2 = 0.1;σ3 = 0.1;R0 = 0.9845108347.
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Figure 4.3: A case with R0 = 1.043287601 and σ0 = 0.
Chosen Values:
β1 = 0.00071; β2 = 0.001775;σ0 = 0;σ1 = 0.05;σ2 = 0.05;σ3 = 0.05;R0 = 1.043287601.
In Fig. 4.1 we haveR0 = 2.938838313 > 1, i.e., the basic reproduction number happens to
be higher than unity, while σ20 < µ. The requirements of Theorem 4.5.1 are therefore not
satisfied, and there does not seem to be convergence. In Figure 4.2 the basic reproduction
numberR0 is found to be less than one and the requirements of Theorem 4.5.1 are fulfilled.
It can be seen that the stochastic solution remains close to the disease-free equilibrium
of the underlying deterministic solution. In Fig. 4.3 we increase the value of β1 and β2,
and we let σ0 = 0. In this case the requirements of Theorem 4.5.1 are not satisfied but
the stochastic solution remains close to the underlying deterministic solution. It may be
that the condition σ0 = 0 permits a stability theorem stronger than Theorem 4.5.1, (cf.
[107]). We also noticed that in most of the simulations (not presented here), when the
intensities of the noise are not too large, then the stochastic solution remains close to the
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underlying deterministic solution. Otherwise strong noise may cause divergence between
stochastic and deterministic behaviours.
4.7 Concluding remarks
Explicit inclusion of stochasticity into epidemiological models by way of Brownian motion
provides further insight into the problem since randomness does feature in real life. In
this chapter, for a treatment model of HIV/AIDS with stochastic perturbations, we have
shown that there are solutions that are feasible (almost surely) in every sense that we have
explored. We also investigated the asymptotic behaviour of the solutions with respect to
the disease-free equilibrium of the underlying deterministic model 4.3. It is important
that even when we would opt to work with the underlying deterministic model, then
there is the assurance that minor random noise will not be catastrophical. There are even
indications that noise on the system may enhance the extinction of the disease. Both
models 4.4 and 4.5 need further investigations meanwhile a model similar to model 4.5
has been studied in Chapter 7.
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Chapter 5
A stochastic model for HIV epidemic
with treatment and inflow of HIV
infectives1
5.1 Introduction
In this chapter, we introduce inflow of infectives on the stochastic compartmental model
of Chapter 4. We present a theorem on almost sure exponential stability of the disease-
free equilibrium. We also study the long term behaviour of the solutions to the stochastic
model around the endemic equilibrium of the underlying deterministic model. Our theo-
retical results are illustrated by simulations with parameters applicable to South Africa.
The dynamics of HIV/AIDS in the context of Southern Africa present serious challenges
due to its complexities and therefore requires interventions. Mathematical modeling in
epidemiology has been utilized to assess the impact of the disease on the population, to
identify key disease drivers and to make future projections. Parameters involved in epi-
1A modified version of this chapter was published as:
M.U. Nsuami, P.J. Witbooi. A STOCHASTIC MODEL FOR HIV EPIDEMIC WITH TREATMENT
AND INFLOW OF INFECTIVES. International Journal of Applied Mathematics, 31(5), (2018) 545-568.
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demic models may not be absolutely constant, due to inhomogeneities and environmen-
tal perturbations. Many authors investigate asymptotic behaviour of stochastic systems
around the equilibria of the underlying deterministic models and examples of those can
be found in [28, 51, 57, 114, 117]. In the papers by [26] Dalal et al. (HIV), [38] Gray
et al. (SIS), [16] Chen et al. (SIR), and [105, 106] Witbooi (SEIR), it is proved that
stochastic perturbation actually enhances stability of the disease-free equilibrium for the
specific models. In this chapter we make another contribution in this regard.
We introduce the inflow of infectives on a deterministic compartmental model, and there-
after we impose the stochastic perturbation in such a manner that the total population
size itself is perturbed by white noise. We study the long term behaviour of the sde model.
We prove a result on almost sure exponential stability of the dfe, in the absence of inflow
of infectives and with no perturbations on the class of susceptibles. We introduce an ana-
logue of the basic reproduction number and we link it to almost sure exponential stability
of the dfe. Here we note that for an sde system the concept of almost sure exponential sta-
bility is very similar to global asymptotic stability when working with ordinary differential
equations. For the case of inflow of infectives we investigate for a type of stability in mean.
The remainder of this chapter is set up as follows. In Section 5.2 we give some prelimi-
naries. In Section 5.3 we present the model and we study the existence of global positive
solutions. Section 5.4 covers a theorem on almost sure exponential stability of the disease-
free equilibrium. We present numerical simulations to illustrate the results. Section 5.5
deals with asymptotic behaviour of the solutions to the stochastic model around the en-
demic equilibrium of the underlying deterministic model. Again we provide numerical
simulations to illustrate our theoretical results. In Section 5.6 we continue to discuss the
long time behaviour of the stochastic system. In Section 5.7 we present some concluding
remarks.
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5.2 Preliminaries
Let us denote by Rn+ (resp. Rn++) the set of points in Rn having only non-negative (resp.
strictly positive) coordinates.
The following observation which we quote from [108] is useful when dealing with expo-
nential stability.
Lemma 5.2.1. For k ∈ N, let X(t) = (X1(t), X2(t), ..., Xk(t)) be a bounded Rk-valued
function and let (t0,n) be any increasing unbounded sequence of positive real numbers.
Then there is a family of sequences (tl,n) such that for each l ∈ {1, 2, ..., k}, (tl,n) is a
subsequence of (tl−1,n) and the sequence Xl(tl,n) converges to the largest limit point of the
sequence Xl(tl−1,n).
5.3 Stochastic HIV Model
Let W (t) = (W0(t),W1(t),W2(t),W3(t)) be a 4-dimensional Wiener process defined on
this probability space. The components of W are assumed to be mutually independent.
The non-negative constants σ0, σ1, σ2 and σ3 denote the intensities of the stochastic per-
turbations.
The parameters Q1, Q2 denote the inflow of infectives into the asymptomatic class and
into the symptomatic class respectively. Based on the above assumptions, we then present
the following stochastic model:
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dS = [µK − c(β1I + β2J)S − µS] dt+ σ0SdW0(t),
dI = [Q1 + c(β1I + β2J)S − (µ+ k1)I + αJ ] dt+ σ1IdW1(t),
dJ = [Q2 + k1I − (µ+ k2 + α)J ] dt+ σ2JdW2(t),
dA = [k2J − (µ+ δ)A] dt+ σ3AdW3(t). (5.1)
In what follows we show that solutions of (5.1) exist globally and are positive.
Let
Rn++ = {x ∈ Rn|xi > 0 for all i = 1, 2, .., n}. (5.2)
Theorem 5.3.1. For model (5.1) and any initial value (S(0), I(0), J(0), A(0)) ∈ R4++,
there is a unique solution (S(t), I(t), J(t), A(t)) on t ≥ 0 which remains in R4++ with
probability one.
Proof. Consider the function V1 below as defined in the proof of Theorem 4.3.1.
V1(S, I, J, A) =
(
S − a0 − a0 ln S
a0
)
+
(
I − 1− ln I
)
+
(
J − 1− ln J
)
+
(
A− 1− lnA
)
.
By applying Itô’s formula we have,
dV1(S, I, J, A) = LV1dt+ (S − a0)σ0dW0(t) + (I − 1)σ1dW1(t)
+(J − 1)σ2dW2(t) + (A− 1)σ3dW3(t), (5.3)
where
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LV1 =
[(
1− a0
S
)(
µK − c(β1I + β2J)S − µS
)]
+
[(
1− 1
I
)(
Q1 + c(β1I + β2J)S
−(µ+ k1)I + αJ
)]
+
[
(1− 1
J
)(Q2 + k1I − (µ+ k2 + α)J)
]
+
[
(1− 1
A
)(k2J − (µ+ δ)A)
]
+ 12(a0σ
2
0 + σ21 + σ22 + σ23)
≤ µK − µ(I + J) + a0c(β1I + β2J) + µ(3 + a0) + k1 + k2 + α + δ
+Q1 +Q2 +
1
2
(
a0σ
2
0 + σ21 + σ22 + σ23).
We choose a0 sufficiently small such that:
a0cβ1I − µI = I (a0cβ1 − µ) < 0 and a0cβ2J − µJ = J (a0cβ2 − µ) < 0.
Therefore
LV1 ≤ C,
where C = µK+µ(3+a0)+k1+k2+α+δ+Q1+Q2+ 12 (a0σ
2
0 + σ21 + σ22 + σ23) is a constant.
The rest of the proof comes readily as in the proof of Theorem 4.3.1. Therefore, the
solution of model (5.1) is positive and will not explode in finite time, with probability
one. This completes the proof.
5.4 Almost sure exponential stability
We investigate the behaviour of the model system (5.1) under small perturbations, with
σ0 = 0, and Q1 = Q2 = 0. Note that we adopt condition σ0 = 0 and Q1 = Q2 = 0 for two
reasons: (1) This is the only condition to obtain a disease-free equilibrium in the case of a
deterministic system by the definition. (2) Convergence of S becomes smooth graphically
and not too complicated. Under these two conditions then, the disease-free equilibrium
E0 = (K, 0, 0, 0) exists. The basic reproduction number of the underlying deterministic
model is computed by
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R0 = cK[β1(µ+ k2 + α) + β2k1](µ+ k1)(µ+ k2) + αµ .
The following subset Φ of sample paths will be of interest.
Φ =
{
ω ∈ Ω| (S(t, ω), I(t, ω), J(t, ω), A(t, ω) ∈ R4++ for all t ≥ 0
}
.
From Theorem 5.3.1 it follows that P(Ω\Φ) = 0. In the remainder of this section we
assume that sample paths are restricted to Φ.
Proposition 5.4.1. If (S(0), I(0), J(0), A(0)) ∈ R4++, then almost surely, S(t) ≤ K for
all t > 0.
Proof. Given any path (in Φ), then
d(S −K)
dt
= −µ(S −K)− c(β1I + β2J)S ≤ −µ(S −K). (5.4)
Therefore S(0) < K implies that S(t) < K for all t > 0.
The following numbers will play a key role in our study of exponential stability. Let
ξ0, ξ1, ξ2, ξ3 and ξ4 be non-negative numbers, chosen as follows.
ξ1 = β1(µ+ k2 + α) + β2k1,
ξ2 = β1α + β2(µ+ k1),
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ξ4 = (µ+ k1)(µ+ k2) + µα.
The numbers ξ0 and ξ3 will be chosen later. For now we just bear in mind that they are
both non-negative.
We continue by preparing notation and concepts for our theorem on almost sure expo-
nential stability. Recall that we work with sample paths in Φ. This implies in particular
that if Z(t) is defined as below, then Z(t) > 0 for all t ≥ 0. Thus we define
Z(t) = ξ0(K − S(t)) + ξ1I(t) + ξ2J(t) + ξ3A(t) (5.5)
and let
V2(t) = lnZ(t).
For a stochastic process x(t) we write
〈x〉t =
1
t
∫ t
0
x(s)ds.
In the following we build a proposition according to definition 2.8.1.
Proposition 5.4.2. The disease-free equilibrium of System (5.1) is almost surely expo-
nentially stable if
lim sup
t→∞
〈LV2(X)〉t < 0 (a.s.).
Proof. We start off by noting that
V2(X(t)) = V2(X(0)) +
∫ t
0
LV2(X(u))du+Mt,
where
Mt =
∫ t
0
(
−ξ0σ0 S(u)
z(X(u))dW0(u) + ξ1σ1
I(u)
z(X(u))dW1(u) + ξ2σ2
J(u)
z(X(u))dW2(u)
+ξ3σ3
A(u)
z(X(u))dW3(u)
)
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The strong law of large numbers for local martingales, see [60, p12] for instance, implies
that
lim
t→∞
1
t
Mt = 0 (a.s.).
Also, we observe that
lim
t→∞
1
t
V2(X(0)) = 0.
Therefore
lim sup
t→∞
1
t
V2(X(t)) = lim sup
t→∞
1
t
∫ t
0
LV2(X(u))du = lim sup
t→∞
〈LV2(X)〉t (a.s.).
This completes the proof.
We now calculate LV2.
LV2 = −ξ0
Z
[µK − c(β1I + β2J)S − µS] + ξ1
Z
[c(β1I + β2J)S − (µ+ k1)I + αJ ]
+ ξ2
Z
[k1I − (µ+ k2 + α)J ] + ξ3
Z
[k2J − (µ+ δ)A]
− 12
(ξ1σ1I
Z
)2
+
(
ξ2σ2J
Z
)2
+
(
ξ3σ3A
Z
)2 .
By Lemma 5.2.1 we can find, for every sample path w, a sequence tn which is increasing
and unbounded, such that
lim sup
t→∞
L〈V2(w)〉t = limn→∞L〈V2(w)〉tn ,
and for which we can define the following limits:
s = lim
n→∞ 〈S〉tn , i = limn→∞
〈
I
Z
〉
tn
, j = lim
n→∞
〈
J
Z
〉
tn
, a = lim
n→∞
〈
A
Z
〉
tn
,
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and
q = lim
n→∞
〈
K − S
Z
〉
tn
.
In particular we note that ξ0q + ξ1i+ ξ2j + ξ3a = 1 and ξ0q, ξ1i, ξ2j, ξ3a ∈ [0, 1].
We define F (ξ) as:
F (ξ) = F (ξ0, ξ1, ξ2, ξ3) = lim sup
t→∞
〈LV2〉t. (5.6)
Then F (ξ) takes the form:
F (ξ) = ξ0 [−µq + c(β1i+ β2j)s] + ξ1 [c(β1i+ β2j)s− (µ+ k1)i+ αj]
+ξ2 [k1i− (µ+ k2 + α)j] + ξ3 [k2j − (µ+ d)a]
−12
[
(ξ1σ1i)2 + (ξ2σ2j)2 + (ξ3σ3a)2
]
. (5.7)
An invariant Rσ of the model (5.1).
Let us define a function h : [0, 1]→ R as follows:
h(u) = ξ1ξ22
(σ1u)2 + σ22(1− u)2
β1ξ2u+ β2ξ1(1− u) . (5.8)
Then h is continuous and positive. Therefore h has a minimum, which we shall denote
by h∗. Note that h∗ > 0. In the final theorem we use the following number Rσ, which we
define to be:
Rσ = cK[β1(µ+ k2 + α) + β2k1](µ+ k1)(µ+ k2) + αµ+ h∗ . (5.9)
Theorem 5.4.3. If Rσ < 1, then restricted to the subset Φ, I and J almost surely
converge exponentially to 0.
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Proof. For ξ1, ξ2 and ξ4 as above (and for ξ0 = ξ3 = 0), we define Z0 = ξ1I + ξ2J and
V0 = lnZ0. It suffices to prove that lim supt→∞〈LV0〉t < 0. Also, we let F0 = F (0, ξ1, ξ2, 0).
We need to prove that F0 < 0.
From (5.7) it follows that
F0 ≤ ξ1 [c(β1i+ β2j)s− (µ+ k1)i+ αj]+ξ2 [k1i− (µ+ k2 + α)j]−12
[
(ξ1σ1i)2 + (ξ2σ2j)2
]
.
This can further be simplified to yield
F0 ≤ ξ1cK(β1i+ β2j)− ξ4(β1i+ β2j)− 12
[
(ξ1σ1i)2 + (ξ2σ2j)2
]
. (5.10)
Now we note that
(ξ1σ1i)2 + (ξ2σ2j)2 =
(ξ1σ1i)2 + (ξ2σ2j)2
β1i+ β2j
(β1i+ β2j),
and since ξ2j = 1− ξ1i, we have
F0 ≤ cKξ1(β1i+ β2j)− ξ4(β1i+ β2j)− h(ξ1i)(β1i+ β2j).
This leads to the inequality below:
F0 ≤ cKξ1(β1i+ β2j)− ξ4(β1i+ β2j)− h∗(β1i+ β2j) = ξ4(Rσ − 1)(β1i+ β2j) < 0.
This completes the proof.
We now prove the main theorem.
Theorem 5.4.4. If Rσ < 1, then the disease-free equilibrium is almost surely exponen-
tially stable.
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Proof. The proof is by contradiction. From Theorem 5.4.3 we know that limt→∞ I(t) = 0
(a.s) and limt→∞ J(t) = 0 (a.s). Let us now suppose, contrary to the claim of this theorem,
that for some subset Θ of Φ with P(Θ) > 0, on Θ we have:
lim
t→∞[(K − S(t)) + A(t)] 6= 0. (5.11)
Now let Z be as in (5.5) and F (ξ) as in (5.7). In particular we choose ξ0 = ξ1 = ξ2 =
ξ3 = ξ4 = 1. Then in view of (5.11) and by the definition of i and j, on Θ we have i = 0
(a.s) and j = 0 (a.s). Thus, from (5.7) it follows that
F (ξ) ≤ −µq − (µ+ δ)a− 12(σ3a)
2 (a.s).
Therefore, F < 0 (a.s). Then by Proposition 5.4.2 it follows that on Θ, we have that
limt→∞(K − S(t)) = 0 (a.s) and limt→∞A(t) = 0 (a.s). This is a contradiction, and it
completes the proof.
5.5 A case study of HIV/AIDS in South Africa.
The parameters such as c, α, k1, k2 found in [9, 41, 40] are applicable to Southern African.
We also assign nominal values to certain parameters. In [40] for instance, the average
number of sexual partners per given time denoted by c has been assigned values ranging
from 1 to 2 for a specific case. In our case we take c = 3 in order to avoid addressing
a problem that is simpler than the actual one. We expect the following inequality holds
β1 < β2, knowing that the probability of disease transmission in the symptomatic phase
far exceeds that of the asymptomatic phase. In the year 2016, the life expectancy in
South Africa was estimated at 62.4 years, see for instance in [90]. The mortality rate µ
is simply the inverse of the life expectancy given by 162.4 yr
−1. The disease induced mor-
tality rate δ is found in [90]. The parameter K is the size of the population and does not
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complicate our task. We estimate values for the inflow of infectives Q1 and Q2 since they
are not easily obtainable. The parameter values of the model are given in the table below.
Table 5.1: Epidemiological data used to estimate initial values for model (5.1)
Parameters Value Source
α 0.33 [9]
k1 0.125 [41]
k2 0.1 [9]
c 3 cf. [40]
µ 162.5 [90]
δ 0.279 [90]
Regarding the initial conditions, we start off by 2016 in order to do our projection. Ac-
cording to the South African 2016 mid-year population estimate [90], the total population
which we denote by N(t16) = S(t16) + I(t16) + J(t16) + A(t16), and where t16 is the time
on 25 August 2016 was 55.91 million. An estimated 7.03 million of the total population
were infected with HIV/AIDS in 2016. This means that the classes of I(t16), J(t16) and
A(t16) add up to 7.03 million. We shall then use the parameters listed in Table 1 to
find a suitable equilibrium point to split the numbers between the classes of I(t16), J(t16)
and A(t16). We keep vary the value of β1 and β2 in order to vary the value of the basic
reproduction number.
Let us denote the force of infection by
λ = c(β1I + β2J).
We note that with inflow of infectives, we find the following equilibrium values for I and
J :
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I = α (λ+ µ) Q2 + (α + µ+ k2) (Kλµ+ (λ+ µ) Q1)(λ+ µ) ((µ+ k1) (µ+ k2) + αµ)
and
J = 1(α + µ+ k2)
[
Q2 + k1
(
α (λ+ µ) Q2 + (α + µ+ k2) (Kλµ+ (λ+ µ) Q1)
(λ+ µ) ((µ+ k1) (µ+ k2) + αµ)
)]
This consideration leads us to assign initial values to I0 and J0, and thus our initial state
is taken as:
S0 = 48.88, I0 = 5.22, J0 = 1.46, A0 = 0.344.
We present some simulations in order to illustrate the analytical results of stochastic
model (5.1) and the underlying deterministic system. For simplicity we use one common
value for σ1, σ2 and σ3 (call it σ) while σ0 = 0. In each graph we show trajectories of J(t)
for the stochastic model and of J(t) for the underlying deterministic model with respect
to time in years.
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Figure 5.1: A case of Rσ < 0, Theorem 5.4.3 guarantees stability.
Chosen values: β1 = 0.000176, β2 = 0.00037, u = 0.9, σ = 0.03. Calculated values:
R0 = 0.967734, Rσ = 0.9557, h = 0.000272349.
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Figure 5.2: Improving stability in the case Rσ < 0 and σ = 0.05.
Chosen values: β1 = 0.000176, β2 = 0.00037, u = 0.9, σ = 0.05. Calculated values:
R0 = 0.967734, Rσ = 0.9350, h = 0.000756524.
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Figure 5.3: Stability obtained beyond R0 < 1 while Rσ < 1.
Chosen values: β1 = 0.000186, β2 = 0.00039, u = 0.9, σ = 0.06. Calculated values:
R0 = 1.022, Rσ = 0.9702, h = 0.00108939.
In Figs. 5.1 and 5.2 we use β1 = 0.000176 and β2 = 0.00037, but with different values of
σ. In both cases Rσ is found to be less than 1. In these cases Theorem 5.4.3 assures us
that the disease-free equilibrium is almost surely exponentially stable. Indeed the graph
shows that over time, the state of the system converges to disease-free equilibrium. It
is also noticed that the convergence to the disease-free equilibrium is faster in Fig. 5.2
than in Fig. 5.1, in line with a lower value of Rσ. In this case, we have expected the
convergence to be faster for a smaller value of Rσ. Fig. 5.3 shows that for small values of
the perturbation parameter there is convergence to disease-free equilibrium for a bigger
range of values of the basic reproduction number of the underlying deterministic model.
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5.6 Asymptotic behaviour around endemic equilib-
rium of the underlying deterministic model
For σ0 6= 0 the model system (5.1) has no endemic equilibrium, but we can investigate
the asymptotic behaviour around the endemic equilibrium of the underlying deterministic
model system.
Before stating the main theorem, let us first define these positive numbers:
B1 = 1 +
2µ+ k2
α
, B2 = µ+
(µ+ k1)(2µ+ k2)
α
,
B3 = 2µ+
(µ+ k1)(2µ+ k2)
α
+ µ(2µ+ k2)
α
, B4 =
2B3
cβ1
(5.12)
Theorem 5.6.1. Let (S(t), I(t), J(t), A(t)) be the solution of system (5.1) with any initial
value (S(0), I(0), J(0), A(0)) ∈ R4++. Let E∗ = (S∗, I∗, J∗, A∗) be an endemic equilibrium
point of the underlying deterministic model. If R0 > 1, and the following condition is
satisfied:
2(µ+ δ)− k2 > 0,
then the solution of model (5.1) has the property:
lim sup
t→∞
1
t
E
∫ t
0
[
(S(τ)− S∗)2 + (I(τ)− I∗)2 + (J(τ)− J∗)2 + (A(τ)− A∗)2
]
dτ ≤ B0
θ
,
where
θ = 2 min {µB1, B2, µ, 2(µ+ δ)− k2} ,
and
B0 = K2(σ20B1 + σ21B1 + σ22 + 2σ23) +
1
2B4
(
S∗σ20 + 2I∗σ21 + A2J∗σ22
)
.
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Proof. We note that at the nontrivial equilibrium point E∗ = (S∗, I∗, J∗, A∗) we have,
µK +Q1 +Q2 = µS∗ + µI∗ + (µ+ k2)J∗
µK +Q2 = µS∗ + (µ+ k1)I∗ − αJ∗
(µ+ δ) = k2
J∗
A∗
. (5.13)
Consider the following function
V3(S, I, J, A) = V4 + V5 + V6 + V7
where
V4 = [(S − S∗) + (I − I∗) + (J − J∗)]2,
V5 =
(2µ+ k2)
α
[(S − S∗) + (I − I∗)]2, V6 = 2(A− A∗)2,
V7 = B4
(
S − S∗ − S∗ ln S
S∗
)
+ 2B4
(
I − I∗ − I∗ ln I
I∗
)
+ A2B4
(
J − J∗ − J∗ ln J
J∗
)
with
A2 =
2αJ∗ + cβ2J∗S∗
k1I∗
.
Then
∫ t
0
dV3(S, I, J, A) =
∫ t
0
LV3du+Rt
=
∫ t
0
[LV4 + LV5 + LV6 + LV7]du+Rt
where
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Rt =
∫ t
0
2[(S − S∗) + (I − I∗) + (J − J∗)](σ0SdW0(u) + σ1IdW1(u) + σ2JdW2(u))
+
∫ t
0
2(2µ+ k2)
α
[(S − S∗) + (I − I∗)](σ0SdW0(u) + σ1IdW1(u))
+
∫ t
0
4(A− A∗)σ3dW3(u) +
∫ t
0
B4(S − S∗)σ0dW0(u) +
∫ t
0
2B4(I − I∗)σ1dW1(u)
+
∫ t
0
A2B4(J − J∗)σ2dW2(u).
We expand the LVi terms as follows
LV4 = 2[(S − S∗) + (I − I∗) + (J − J∗)][−µ(S − S∗)− µ(I − I∗)− (µ+ k2)(J − J∗)]
+(σ20S2 + σ21I2 + σ22J2),
LV5 = 2(2µ+ k2)
α
[(S − S∗) + (I − I∗)][−µ(S − S∗)− (µ+ k1)(I − I∗) + α(J − J∗)],
+(2µ+ k2)
α
(σ20S2 + σ21I2),
LV6 = 4(A− A∗)[k2(J − J∗)− (µ+ δ)(A− A∗)] + 2σ23A2,
LV7 = µS∗B4
(
2− S
S∗
− S
∗
S
)
−B4
(
1− S
∗
S
)
cβ1(IS − I∗S∗) + 2B4
(
2− I
I∗
− I
∗
I
)
Q1
−B4
(
1− S
∗
S
)
cβ2(JS − J∗S∗) + 2B4cβ1 (I − I∗) (S − S∗)
+2B4
(
1− I
∗
I
)
cβ2
(
JS − J∗S∗ I
I∗
)
+ 2B4α
(
1− I
∗
I
)(
J − J∗ I
I∗
)
+A2B4
(
1− J
∗
J
)(
k1I − k1I∗ J
J∗
)
+ A2B4
(
2− J
J∗
− J
∗
J
)
Q2
+12B4
(
S∗σ20 + 2I∗σ21 + A2J∗σ22
)
.
Let us compute LV4,LV5 and LV6 in detail.
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LV4 = −2µ(S − S∗)2 − 4µ(S − S∗)(I − I∗)− 2(2µ+ k2)(S − S∗)(J − J∗)
−2(2µ+ k2)(I − I∗)(J − J∗)− 2µ(I − I∗)2 − 2(µ+ k2)(J − J∗)2
+(σ20S2 + σ21I2 + σ22J2)
LV5 = −2µ(2µ+ k2)
α
(S − S∗)2 − 2(µ+ k1)(2µ+ k2)
α
(I − I∗)2
−2
(
(µ+ k1)(2µ+ k2)
α
+ µ(2µ+ k2)
α
)
(S − S∗)(I − I∗)
+2(2µ+ k2)(S − S∗)(J − J∗) + 2(2µ+ k2)(I − I∗)(J − J∗)
+(2µ+ k2)
α
(σ20S2 + σ21I2)
LV6 = 4k2(A− A∗)(J − J∗)− 4(µ+ δ)(A− A∗)2 + 2σ23A2.
Thus we have,
LV3 = −2µB1(S − S∗)2 − 2B2(I − I∗)2 − 2(µ+ k2)(J − J∗)2
−2B3(S − S∗)(I − I∗) + 4k2(A− A∗)(J − J∗)− 4(µ+ δ)(A− A∗)2
+σ20S2B1 + σ21I2B1 + σ22J2 + 2σ23A2 + LV7 (5.14)
where B1, B2 and B3 are as in (5.12).
Following the inequality (4.2) in remark 4.2.3, regarding the second term in line two for
equation (5.14) we get
2(A− A∗)(J − J∗) ≤ (A− A∗)2 + (J − J∗)2.
Now from (5.14) we obtain the inequality:
LV3 ≤ −2µB1 (S − S∗)2 − 2B2 (I − I∗)2 − 2µ (J − J∗)2
−2(2(µ+ δ)− k2) (A− A∗)2 +K2(σ20B1 + σ21B1 + σ22 + 2σ23)
−2B3(S − S∗)(I − I∗) + LV7
≤ Λ, (5.15)
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where
Λ = LV7 − 2B3(S − S∗)(I − I∗) +K2(σ20B1 + σ21B1 + σ22 + 2σ23).
Then
Λ = µS∗B4
(
2− S
S∗
− S
∗
S
)
−B4
(
1− S
∗
S
)
cβ1(IS − I∗S∗) + 2B4
(
2− I
I∗
− I
∗
I
)
Q1
−B4
(
1− S
∗
S
)
cβ2(JS − J∗S∗) + 2B3 (I − I∗) (S − S∗)
+2B4
(
1− I
∗
I
)
cβ2
(
JS − J∗S∗ I
I∗
)
+ 2B4α
(
1− I
∗
I
)(
J − J∗ I
I∗
)
+A2B4
(
1− J
∗
J
)(
k1I − k1I∗ J
J∗
)
+ A2B4
(
2− J
J∗
− J
∗
J
)
Q2
+12B4
(
S∗σ20 + 2I∗σ21 + A2J∗σ22
)
+K2(σ20B1 + σ21B1 + σ22 + 2σ23).
Letting S
S∗ = x,
I
I∗ = y,
A
A∗ = z, it follows that
Λ = S∗(B4µ+ 2B3I∗)
(
2− 1
x
− x
)
+ 2B4αJ∗
(
2− z
y
− y
z
)
+B4Scβ2J∗
(
3− xz
y
− 1
x
− y
z
)
+ 2B4
(
2− 1
y
− y
)
Q1
+12B4
(
S∗σ20 + 2I∗σ21 + A2J∗σ22
)
+ A2B4
(
2− 1
z
− z
)
Q2
+K2(σ20B1 + σ21B1 + σ22 + 2σ23).
Note that since the arithmetic mean is greater than or equal to the geometric mean, it
follows that
1
y
+ y ≥ 2, 1
x
+ x ≥ 2, z
y
+ y
z
≥ 2, 1
x
+ xz
y
+ y
z
≥ 3.
We now have
Λ ≤ 12B4
(
S∗σ20 + 2I∗σ21 + A2J∗σ22
)
+K2(σ20B1 + σ21B1 + σ22 + 2σ23). (5.16)
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Substituting (5.16) into (5.15), it follows that
LV3 ≤ −2µB1 (S − S∗)2 − 2B2 (I − I∗)2 − 2µ (J − J∗)2
−2(2(µ+ δ)− k2) (A− A∗)2 +K2(σ20B1 + σ21B1 + σ22 + 2σ23)
+12B4
(
S∗σ20 + 2I∗σ21 + A2J∗σ22
)
.
Hence ∫ t
0
dV3 ≤
∫ t
0
[−2µB1(S − S∗)2 − 2B2(I − I∗)2 − 2µ(J − J∗)2
−2(2(µ+ δ)− k2)(A− A∗)2 +K2(σ20B1 + σ21B1 + σ22 + 2σ23)
+12B4(S
∗σ20 + 2I∗σ21 + A2J∗σ22)]du+Rt.
We take expectation and note that E[Rt] = 0. Thus we obtain
0 ≤ E[V3(S(t), I(t), J(t), A(t))] ≤ E[V3(S(0), I(0), J(0), A(0))]
+E
∫ t
0
[−2µB1(S − S∗)2 − 2B2(I − I∗)2 − 2µ(J − J∗)2
−2(2(µ+ δ)− k2)(A− A∗)2 +B0]du, (5.17)
which gives
E
∫ t
0
[
2µB1 (S(u)− S∗)2 + 2B2 (I(u)− I∗)2 + 2µ (J(u)− J∗)2
+2(2(µ+ δ)− k2) (A(u)− A∗)2
]
du
≤ E[V3(S(0), I(0), J(0), A(0))] +B0t.
Therefore,
lim sup
t→∞
1
t
E
∫ t
0
[
2µB1 (S(u)− S∗)2 + 2B2 (I(u)− I∗)2 + 2µ (J(u)− J∗)2
+2(2(µ+ δ)− k2) (A(u)− A∗)2
]
du ≤ B0.
We take θ as in the formulation of Theorem 5.6.1, and then it follows that:
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lim sup
t→∞
1
t
E
∫ t
0
[
(S(τ)− S∗)2 + (I(τ)− I∗)2 + (J(τ)− J∗)2 + (A(τ)− A∗)2
]
dτ ≤ B0
θ
,
This completes the proof.
Remark 5.6.2. Theorem 5.6.1 states that for small values of the perturbation parameters
the solutions of the stochastic system (5.1) will eventually stay very close to the endemic
equilibrium of the underlying deterministic model.
We present numerical simulations in the general case as well as in the case the South-
African historical HIV data with parameter values given in Table 5.2.
Table 5.2: Parameters estimates for the simulation of model system 5.1 in the general
context.
Parameters Value Source
µ 0.02 [8]
α 0.33 [8]
k1 0.125 [41]
k2 0.1 [8]
c 3 Estimate
δ 0.333 [8]
b 2.5 Estimate
K 6.5 Nominal
with the initial conditions: S0 = 4.5, I0 = 1, J0 = 0.6, A0 = 0.4. In each graph we
show two trajectories of the stochastic model (one sample path) and of the underlying
deterministic model.
87
http://etd.uwc.ac.za/
0 50 100 150 200 250 300 350 400
4.4
4.6
4.8
5
5.2
5.4
5.6
5.8
6
6.2
6.4
time in years
Su
sc
ep
tib
le 
po
pu
lat
ion
 in
 m
illi
on
s
 
 
Deterministic
Stochastic
(a)
0 50 100 150 200 250 300 350 400
0
0.2
0.4
0.6
0.8
1
1.2
1.4
time in years
As
ym
pt
om
at
ic 
po
pu
lat
ion
 in
 m
illi
on
s
 
 
Deterministic
Stochastic
(b)
0 50 100 150 200 250 300 350 400
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
time in years
Sy
m
pt
om
at
ic 
po
pu
lat
ion
 in
 m
illi
on
s
 
 
Deterministic
Stochastic
(c)
0 50 100 150 200 250 300 350 400
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
time in years
HI
V/
AI
DS
 p
op
ula
tio
n 
in 
m
illi
on
s
 
 
Deterministic
Stochastic
(d)
Figure 5.4: β = 0.00165, Q1 = Q2 = 0, σ0 = 0.002, σ1 = 0.01, σ2 = 0.02, σ3 = 0.02,
R0 = 1.022,B1 = 1.42, B2 = 0.0815
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Figure 5.5: β = 0.00165, Q1 = Q2 = 0.005, σ0 = 0.002, σ1 = 0.01, σ2 = 0.02, σ3 = 0.02,
R0 = 1.022, B1 = 1.42, B2 = 0.0815
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Figure 5.6: β = 0.00254, Q1 = Q2 = 0.005, σ0 = 0.25, σ1 = 0.28, σ2 = 0.22, σ3 = 0.02,
R0 = 1.574, B1 = 1.42, B2 = 0.0815
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Figure 5.7: β = 0.00550, Q1 = Q2 = 0, σ0 = 0.25, σ1 = 0.25, σ2 = 0.25, σ3 = 0.2,
R0 = 3.407, B1 = 1.42, B2 = 0.0815 .
In the special case, the initial state is taken as:
S0 = 48.88; I0 = 5.22; J0 = 1.46;A0 = 0.344.
We present numerical simulations in order to illustrate the results of Theorem 5.5.1 with
parameter values given in Table 1.
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Figure 5.8: The dynamics of model system (5.1) without the inflow of infectives:
Chosen values: β1 = 0.0002904, β2 = 0.00061, Q1 = Q2 = 0, σ0 = 0.005, σ1 = 0.004, σ2 =
0.009, σ3 = 0.01. Calculated value: R0 = 1.595, λ = 0.009527, S∗ = 35.04, I∗ = 6.88, J∗ =
1.92, A∗ = 0.65.
In Fig. 5.8 the basic reproduction number R0 is bigger than one and the stochastic so-
lutions remain close to the endemic solutions of the underlying deterministic model. We
observe a similar pattern in these graphs. In Fig. 5.9 all the parameters and their values
have remained unchanged, except that the inflow of infectives Q1, Q2 now are taken as
positive. In the case of the underlying deterministic model, the inflow of infectives lead to
increasing the values of the force of infection λ, I, J and A while decreasing the value of
S. In the stochastic case, the fluctuation in each graph is higher than the fluctuations in
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Figure 5.9: The dynamics of model system (5.1) with inflow of infectives:
Chosen values: β1 = 0.0002904, β2 = 0.00061, Q1 = Q2 = 0.005, σ0 = 0.005, σ1 =
0.004, σ2 = 0.009, σ3 = 0.01. Calculated value: R0 = 1.595, λ = 0.01022, S∗ = 34.12, I∗ =
7.37, J∗ = 2.077, A∗ = 0.70.
Fig. 5.8 due to the inflow of infectives. In Fig. 5.10, for Q1 = Q2 = 0.005, we increase the
values of stochastic perturbations. In this case, strong perturbation has led to a strong
divergence and we do not expect the stochastic solutions to be close to the endemic solu-
tions of the underlying deterministic system.
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Figure 5.10: The dynamics of model system (5.1) with big stochastic perturbations:
Chosen values: β1 = 0.0002904, β2 = 0.00061, Q1 = Q2 = 0.005, σ0 = 0.04, σ1 = 0.03,
σ2 = 0.06, σ3 = 0.06. Calculated value: R0 = 1.595, λ = 0.01022, S∗ = 34.12, I∗ =
7.37, J∗ = 2.077, A∗ = 0.70.
5.7 Concluding remarks
We have presented an sde model of HIV, which we showed to have well-behaved solu-
tions. In the special case that we have no inflow of infected individuals into the system
and σ0 = 0, Theorem 5.4.3 describes convergence to disease-free equilibrium. In particu-
lar, the theorem asserts that for sufficiently small values of the perturbation parameter,
stability of the disease-free equilibrium is obtained for a bigger range of values of the
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basic reproduction number R0 of the deterministic model, i.e., beyond the range R0 < 1.
This is sufficiently significant that it can be observed in simulations. The almost sure
exponential stability is a fairly strong type of stability, it being a stochastic version of
global asymptotic stability. For the public health authorities it is comforting to know that
the presence of minor stochasticity on their model will not be a hindrance if eradication
strategies should be launched. However, although South Africa has more people infected
with HIV, the country has kept many HIV infected people alive, due to it being among
countries having the largest ART programmes in the world. The ART treatment has
improved the lives of many individuals with HIV in the world and particularly in South
Africa, but it is known that treatment without behavioural change may even lead to high
prevalence of AIDS. With respect to the general model, we have been able to describe
the long-term behaviour of solutions in comparison with that of the deterministic model,
in Theorem 5.6.1. The theorem asserts that asymptotically the stochastic solutions stay
within a certain bound from the (non-trivial) equilibrium point of the underlying deter-
ministic model. This is very well observed in simulations. Further it is also investigated
that the positive flow of infectives could affect the stability and also lead the dynamics
of the model system from stable to the unstable situation. Our sde model has revealed
some new phenomena and is useful when planning intervention strategies.
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Chapter 6
A model of HIV/AIDS population
dynamics including ARV treatment
and pre-exposure prophylaxis1
6.1 Introduction
We investigate a deterministic compartmental model for HIV/AIDS epidemic model in-
cluding ARV treatment and the use of oral prophylaxis. Antiretroviral treatment (ART)
and oral pre-exposure prophylaxis (PrEP) have recently been used efficiently in manage-
ment of HIV infection. Pre-exposure prophylaxis consists in the use of an antiretroviral
medication to prevent the acquisition of HIV infection by uninfected individuals. We pro-
pose a new model for the transmission of HIV/AIDS including ART and PrEP. Our model
can be used to test the effects of ART and of the uptake of PrEP in a given population,
as we demonstrate through simulations. The model can also be used to estimate future
projections of HIV prevalence. We prove global stability of the disease-free equilibrium.
We also prove global stability of the endemic equilibrium for the most general case of the
1A modified version of this chapter was published as:
M.U. Nsuami, P.J. Witbooi. A model of HIV/AIDS population dynamics including ARV treatment and
pre-exposure prophylaxis. Advances in Difference Equations, 2018(1), (2018) 11.
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model, i.e., which allows for PrEP individuals to default. We include insightful simula-
tions based on recently published South-African data.
The aim of this chapter is to demonstrate the extent to which PrEP can possibly reduce
the prevalence of the HIV in a large population such as South Africa, in the presence
of treatment. We introduce a model with two stages of infection and we assume that
susceptible individuals have access to PrEP to prevent themselves from HIV. Such indi-
viduals become exposed to HIV once they stop taking oral PrEP. The model allows for
individuals in the asymptomatic phase to move back to the asymptomatic phase after
successful treatment.
The remainder of this chapter is set up as follows. In Section 6.2 we present the model.
We calculate the basic reproduction number and prove existence of positive solutions.
Section 6.3 covers both global stability of the disease-free and endemic equilibrium. In
Section 6.4 we provide numerical simulations to illustrate our theoretical results and the
utility of the model. In Section 6.5 we offer some concluding remarks.
6.2 The model
6.2.1 Model description
We consider a population with homogeneous mixing of individuals, of size N(t) at time
t. The total size N(t) is assumed to be sufficiently large in order to approximate the
population as a continuum of points. These are general assumptions for modeling with
ordinary differential equations, see for instance [3] of Anderson and May. For this model,
the population is subdivided into the classes of susceptibles S(t), the asymptomatic phase
I1(t) of HIV, the symptomatic phase I2(t), the AIDS patients A(t) and the individuals
under PrEP E(t), so that
N(t) = S(t) + I1(t) + I2(t) + A(t) + E(t).
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Figure 6.1: Flow diagram of HIV/AIDS model with PrEP
Our model is then constructed by considering the appropriate in-flow and out-flow rates
of as in the diagram above
dS
dt
= µK − c(β1I1 + β2I2)S − (µ+ φ)S + θE,
dI1
dt
= c(β1I1 + β2I2)S − (µ+ k1)I1 + αI2,
dI2
dt
= k1I1 − (µ+ k2 + α)I2,
dA
dt
= k2I2 − (µ+ δ)A,
dE
dt
= φS − (µ+ θ)E ; (6.1)
S(0) = S0 > 0, I1(0) = I1,0 > 0, I2(0) = I2,0 > 0, A(0) = A0 > 0, E(0) = E0 > 0.
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The functions S(t), I1(t), I2(t), A(t) and E(t) are assumed to be continuous. We introduce
the following parameters that appear in the model equations:
µ Birth and mortality rates by natural causes,
K The size of the total population when disease-free,
c The average number of sexual contacts of one individual with others, per unit time,
β1 The probability of disease transmission in the asymptomatic phase,
β2 The probability of disease transmission in the symptomatic phase,
φ The proportion of susceptible individuals under PrEP,
θ The proportion of susceptible individuals who default PrEP,
k1 Progression rate from I1 to I2,
k2 Progression rate from the symptomatic phase I2 to A,
α The rate of transfer from I2 to I1 due to ARV treatment,
δ Disease induced mortality rate.
The model system (6.1) permits a disease-free equilibrium Σ0 =
(
(µ+θ)K
(µ+φ+θ) , 0, 0, 0,
φK
(µ+φ+θ)
)
and an endemic equilibrium Σ∗ = (S∗, I∗1 , I∗2 , A∗, E∗) with the coordinates
S∗ = µK(µ+ θ)(µ+ θ)(λ+ µ) + µφ,
I∗1 =
λ(µ+ k2 + α)µK(µ+ θ)
[(µ+ k2)(µ+ k1) + µα][(µ+ θ)(λ+ µ) + µφ]
I∗2 =
k1λµK(µ+ θ)
[(µ+ k2)(µ+ k1) + µα][(µ+ θ)(λ+ µ) + µφ]
A∗ = k1k2λµK(µ+ θ)[(µ+ k2)(µ+ k1) + µα][(µ+ θ)(λ+ µ) + µφ]
E∗ = µKφ(µ+ θ)(λ+ µ) + µφ.
where
λ = c(β1I∗1 + β2I∗2 ).
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Following the method expounded in [98] the basic reproduction number of the model is
calculated as
R0 = c(µ+ θ)K(β1(µ+ k2 + α) + β2k1)(µ+ φ+ θ)((µ+ k1)(µ+ k2) + αµ) .
6.2.2 Feasible solutions
Let us introduce the set Ω,
Ω =
{
x ∈ R5| xi > 0, i = 1, 2, 3, 4, 5 and x1 + x2 + x3 + x4 + x5 < K
}
.
Theorem 6.2.1. Assume that X(t) is a solution of the system (6.1) with X(0) ∈ Ω.
Then X(t) ∈ Ω for all t > 0.
Proof. The proof is by contradiction. Let X(t) be a solution of the system (6.1) where
X(0) ∈ Ω. Suppose to the contrary that there exists a t0 > 0 such that X(t0) /∈ Ω. Let
T = inf{t > 0 : X(t) /∈ Ω}. Since Ω is an open set due to continuity of X(t), T is strictly
positive.
Choose a0 > 0 sufficiently small in order to have a0cβ1 < µ and a0cβ2 < µ. Consider the
function V1 defined by
100
http://etd.uwc.ac.za/
V1(t) =
(
S − a0 ln S
a0
)
+
(
I1 − ln I1
)
+
(
I2 − ln I2
)
+
(
A− lnA
)
+
(
E − lnE
)
(6.2)
Note that for every T < t, each of the five bracketed terms on the right hand side of
equation (6.2) are positive while (S, I1, I2, A,E) ∈ Ω.
Now we find an upper bound for the set
G = {V1(t) : 0 < t < T}.
We note that for any 0 < t < T ,
V˙1(t) =
[(
1− a0
S
)(
µK − c(β1I1 + β2I2)S − (µ+ φ)S + θE
)]
+
[(
1− 1
I1
)(
c(β1I1 + β2I2)S
−(µ+ k1)I1 + αI2
)]
+
[
(1− 1
I2
)(k1I1 − (µ+ k2 + α)I2)
]
+
[
(1− 1
A
)(k2I2 − (µ+ δ)A)
]
+
[
(1− 1
E
)(φS − (µ+ θ)E)
]
= µK − a0
S
µK − µ(S + I1 + I2 + A+ E)− a0
S
θE + a0(µ+ φ) + a0c(β1I1 + β2I2)
− 1
I1
c(β1I1 + β2I2)S + (µ+ k1)− 1
I1
αI2 + (µ+ k2 + α)− 1
A
k2I2 + (µ+ δ)
− 1
E
φS + (µ+ θ)
≤ µK − µ(I1 + I2) + a0c(β1I1 + β2I2) + 4µ+ a0(µ+ φ) + k1 + k2 + α + δ + θ.
Note that by the choice of a0 we have:
a0cβ1I1 − µI1 = I1 (a0cβ1 − µ) < 0 and a0cβ2I2 − µI2 = I2 (a0cβ2 − µ) < 0.
Therefore
V˙1(t) ≤ C,
where C = µK + 4µ+ a0(µ+ φ) + k1 + k2 + α + δ + θ.
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Integrating from 0 to t yields
V1(t) = V1(0) +
∫ t
0
V˙1(s)ds ≤ V1(0) + Ct ≤ V1(0) + CT. (6.3)
However, we note that for any positive constant q,
lim
x→0+
(
x− q ln x
q
)
=∞.
Now further, due to positivity of the bracketed terms on the right hand side of equation
(6.2), it follows that
lim
t→T
V1(t) =∞. (6.4)
The equation (6.4) is in conflict with the inequality (6.3). Thus we have arrived at a
contradiction.
6.3 Stability analysis
6.3.1 Global stability of the disease-free equilibrium
The following positive numbers are useful in the proof of the global stability of disease-free
equilibrium.
ξ1 = µ+ k2 + α + k1
β2
β1
, ξ2 = α +
β2
β1
(µ+ k1), ξ4 = (µ+ k1)(µ+ k2) + αµ.
Theorem 6.3.1. If R0 < 1, then the disease-free equilibrium Σ0 of system (6.1) is globally
asymptotically stable.
Proof. We introduce a number Λ as:
Λ = (µ+ θ)K
µ+ φ+ θ .
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Assuming that R0 < 1, it is possible to find positive numbers ξ0 and ξ3 sufficiently small
such as to have the following inequality:
C2 = ξ0cβ2Λ + ξ3k2 + ξ4(R0 − 1) < 0.
Using such ξ0 and ξ3, together with the numbers ξi introduced already, we define a function
V2 as follows.
V2(t) = ξ0[K − (S + E)] + ξ1I1 + ξ2I2 + ξ3A. (6.5)
The time derivative of V2(t) is given by:
V˙2(t) = ξ0[−µ(K − (S + E)) + c(β1I1 + β2I2)S] + ξ1 [c(β1I1 + β2I2)S − (µ+ k1)I1 + αI2]
+ξ2 [k1I1 − (µ+ k2 + α)I2] + ξ3 [k2I2 − (µ+ δ)A] .
Grouping some terms we have:
V˙2(t) ≤ C0[K − (S + E)] + C1I1 + C2I2 + C3A
where
C0 = −µξ0 < 0,
C1 = ξ0cβ1Λ + ξ1cβ1Λ− (µ+ k1)ξ1 + ξ2k1,
C2 = ξ0cβ2Λ + ξ1cβ2Λ− (µ+ k2 + α)ξ2 + ξ3k2 + ξ1α,
C3 = −(µ+ δ)ξ3 < 0.
Now we show that the coefficients C1, C2 are also negative. Firstly, it is easy to see that
−(µ+ k1)ξ1 + ξ2k1 = −ξ4 = −((µ+ k1)(µ+ k2) + αµ).
It follows that
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C1 = ξ0cβ1Λ + ξ1cβ1Λ− ξ4 = ξ0cβ1Λ + ξ4(R0 − 1) < 0.
Further, notice that
−(µ+ k2 + α)ξ2 + ξ1α = −ξ4β2
β1
.
Thus, we have
ξ1cβ2Λ− ξ4β2
β1
= ξ4(R0 − 1).
Therefore,
C2 = ξ0cβ2Λ + ξ3k2 + ξ4(R0 − 1) < 0,
confirming that V2 is a Lyapunov function. This completes the proof.
6.4 Global stability of the endemic equilibrium
We investigate global stability of the endemic equilibrium of model (6.1) in the general
case, that is when θ 6= 0 and in particular case, when θ = 0.
Theorem 6.4.1. Assume that R0 > 1 and θE∗ < cβ1I∗1S∗. Then the endemic equilibrium
Σ∗ of system (6.1) is globally asymptotically stable .
Proof. Consider a function V3 of the form:
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V3(t) =
(
S − S∗ − S∗ ln S
S∗
)
+D1
(
I1 − I1∗ − I1∗ ln I1
I1
∗
)
+D2
(
I2 − I∗2 − I2∗ ln
I2
I2
∗
)
+D3
(
A− A∗ − A∗ ln A
A
∗)
+D4
(
E − E∗ − E∗ ln E
E
∗)
,
where D1, D2, D3 and D4 are positive constants, to be determined at a later stage.
The (endemic) equilibrium values of the system (6.1) satisfy the following equations:
µK = S∗(β1I1∗ + β2I2∗)c+ (µ+ φ)S∗ − θE∗
(µ+ k2 + α) = k1
I1
∗
I2
∗
(µ+ k1) =
S∗
I1
∗ (β1I1∗ + β2I2∗)c+ α
I2
∗
I1
∗
(µ+ δ) = k2
I∗2
A∗
(µ+ θ) = φS
∗
E∗
.
The time derivative of V3(t) is given by
V˙3(t) = cβ1
(
1− S
∗
S
)
(I∗1S∗ − I1S) + cβ2
(
1− S
∗
S
)
(I∗2S∗ − I2S)
+
(
2− S
S∗
− S
∗
S
)
S∗(µ+ φ) +
(
1− I
∗
1
I1
)
D1cβ1 (I1S − I1S∗)
+
(
1− I
∗
1
I1
)
D1cβ2
(
I2S − I∗2S∗
I1
I∗1
)
+ (E − E∗) θ
(
1− S
∗
S
)
+D3
(
1− A
∗
A
)
k2
(
I2 − I∗2
A
A∗
)
+D2
(
I1 − I∗1
I2
I∗2
)(
1− I
∗
2
I2
)
k1
+
(
1− E
∗
E
)
D4
(
S − S∗ E
E∗
)
φ. (6.6)
Let
x = S
S∗
, y = I1
I∗1
, z = I2
I∗2
, v = A
A∗
, w = E
E∗
.
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Then (6.6) becomes
V˙3(t) = S∗(µ+ φ)
(
2− 1
x
− x
)
+D1cβ1I∗1S∗
(
1− 1
y
)
(xy − y) +D1cβ2I∗2S∗
(
1− 1
y
)
(xz − y)
+D2I∗1k1
(
1− 1
z
)
(y − z) +D3I∗2k2
(
1− 1
v
)
(z − v) + αD1I∗2
(
1− 1
y
)
(z − y)
+D4k2
(
1− 1
w
)
φS∗(x− w) + cβ1I∗1S∗
(
1− 1
x
)
(1− xy)
+cβ2I∗2S∗
(
1− 1
x
)
(1− xz) +
(
1− 1
x
)
(x− 1)θE∗. (6.7)
This equation informs a choice of values for the numbers Di, in order to render V3 a
Lyapunov function. For making our choices, we require the numbers Di to satisfy the
following equations.
(D1 − 1) = 0
−D2I∗1k1 + αD1I∗2 +D3I∗2k2 + cβ2I∗2S∗ = 0
−D1cβ1I∗1S∗ −D1cβ2I∗2S∗ +D2I∗1k1 − αD1I∗2 + cβ1I∗1S∗ = 0
−D1cβ1I∗1S∗ +D4k2φS∗ + θE∗ = 0
This leads to the following Di-values:
D1 = 1, D2 =
cβ2S
∗I2∗ + αI2∗
k1I1
∗ , D3 =
D2k1I
∗
1 − (cβ2S∗I2∗ + αI∗2 )
k2I∗2
.
D4 =
cβ1I
∗
1S
∗ − θE∗
k2φS∗
.
Substituting back the Di terms in (6.7), we have
V˙3(t) = S∗(µ+ φ)
(
2− 1
x
− x
)
+ cβ2S∗I2∗
(
3− 1
x
− xz
y
− y
z
)
+αI2∗
(
2− z
y
− y
z
)
+ (cβ1I∗1S∗ − θE∗)
(
3− w − 1
x
− x
w
)
≤ 0.
This complete the proof.
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In particular, we have the following corollary:
Corollary 6.4.2. If θ = 0, then the endemic equilibrium Σ∗ of system (6.1) is globally
asymptotically stable for R0 > 1.
6.5 Numerical simulation
The model can be used to test the efficiency of a given intervention. In particular, au-
thorities may want to see the effect of, for example, expanding the use of PrEP. Thus,
simulations in this context will also be shown.
We illustrate the analytical results by way of numerical simulations with the parameters
applicable to South Africa as in Table 1 below:
Table 6.1: Estimating initial values for model system (6.1) based on parameters and their
fixed values
Parameters Value Source
α 0.33 [9]
k1 0.125 [41]
k2 0.1 [9]
c 3 cf. [40, 71]
δ 0.279 [90]
µ 162.4 [90]
φ 0.01 Nominal
θ 0.001 Nominal
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6.5.1 Details on the description of parameters and their values
In [40, 71] for instance, the average number of sexual partners per given time denoted
by c is determined; values ranging from 1 to 2 for a specific case. In our case we find it
convenient to take c = 3. We expect the following inequality, β1 < β2, to hold since the
intensity of disease transmission in the symptomatic phase exceeds that of the asymp-
tomatic phase. In the year 2016, the life expectancy in South Africa was estimated at
62.4 years, see for instance [90]. The mortality rate µ is simply the inverse of the life
expectancy, and thus µ = 162.4year
−1. The parameter K is the size of the population
when it is free from HIV. According to [90], in 2016 South Africa had an estimated total
population 55.91 million. Thus we consider it reasonable to choose K = 56 million. We
assume that 1% of the susceptible individuals take PrEP, that is, φ = 0.01 and the default
rate takes the value θ = 0.001.
6.5.2 Initial conditions
For initial conditions, we first refer to the South African statistical release [90] of 2016 in
order to do some projections. Let us denote the time 25 August 2016 by t0. We note that
N(t0) = S(t0) + I1(t0) + I2(t0) + A(t0) + E(t0).
An estimated 7.03 million of the total population were infected with HIV/AIDS in 2016.
This number can be split between the classes of I1(t0), I2(t0) and A(t0). We shall then
use the parameters listed in Table 1 below to find a suitable equilibrium point to split the
numbers between the classes of I1(t0), I2(t0) and A(t0). In this process we keep varying
the value of β1 and β2 in order to vary the value of the basic reproduction number. This
method leads to the following initial values for our simulations:
I1,0 = 5.11, I2,0 = 1.43, A0 = 0.48.
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We note that in endemic equilibrium,
E∗ = φ
µ+ θS
∗.
Therefore, we consider it reasonable to use the initial value
E(t0) =
1
50
φ
µ+ θS(t0).
This consideration leads us to assign initial values to S0 and E0, and thus our initial state
for these two initial values are taken as:
S0 = 46.18, E0 = 1.12 .
6.5.3 Simulations on the effect of PrEP
In the following we show the trajectories of I1(t), I2(t), A(t) of the model for φ = 0.01
in Fig. 6.1, and in Fig. 6.2 the trajectories of I2(t) for different values of φ, φ =
0.01, 0.02, 0.03. For the different values of φ, the corresponding value of R0 will be
denoted by R0(φ).
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Figure 6.2: Population dynamics of the model for the case φ = 0.01.
In both Figure 6.1 and Figure 6.2 we have chosen the values: β1 = 0.000481, β2 =
0.000581. In figure 6.1 we compute the basic reproduction number, R0(0.01) = 1.401 > 1.
The trajectories show that the disease is prevailing at the endemic level. We also compute
the endemic equilibrium points I∗1 = 5.28, I∗2 = 1.48 and A∗ = 0.50 (in millions). In Figure
6.2, we show the graph of I2(t) with different values of φ. In the case φ = 0.02, the basic
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Figure 6.3: Comparing the class of symptomatic infectives, I2, for different values of φ.
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Figure 6.4: Population of susceptibles and individuals with PrEP
Chosen values: β1 = 0.000481, β2 = 0.000581, φ = 0.01. Calculated values:
R0(0.01) = 1.414, S∗ = 25.1157, E∗ = 14.7739.
reproduction number reduces to R0(0.02) = 1.021. This is due to increasing uptake of
PrEP from 0.01 to 0.02, and we observe the increase in the uptake of PrEP has decreased
the basic reproduction number and the class of I2(t). The equilibrium value is computed
by I∗2 = 0.12. The same scenario is also very well observed in the simulation for the
case where φ = 0.03. In this case, the basic reproduction number is found to be below
unity, that is, R0(0.02) = 0.8039. The class of I2(t) converges to zero. We note I∗2 is a
decreasing function of φ. We note that also the long term (or asymptotic) values of I1
and A are decreasing functions of φ. In Fig. 6.3 we show the dynamics of the population
of susceptibles and of the individuals with PrEP.
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6.6 Concluding remarks
In this paper, we have investigated a model describing the population dynamics of HIV/AIDS
including treatment and pre-exposure prophylaxis (PrEP) in the context of South Africa.
We proved global stability of disease-free and endemic equilibria, Theorem 6.3.1 and
Theorem 6.4.1 respectively. Our analytical results and our sample simulations are quite
meaningful as we work with the current HIV trend in South Africa. We showed the
substantial impact that treatment has on the incidence, prevalence and mortality due to
AIDS. Managing HIV with early treatment can decrease transmission and possibly de-
crease the number of AIDS related deaths. Our model quantifies how the use of PrEP can
potentially reduce the number of new HIV infections, and this has been well observed in
the sample simulations. South Africa has a wide range of its population being exposed to
HIV. Its high-risk sections of the population include adolescent girls and young women,
sex workers, men who have sex with men (MSM), discordant couples and truckers, all of
whom face various barriers to access including stigma, criminalisation and lack of sup-
portive service delivery infrastructure [21].
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Chapter 7
A Stochastic HIV/AIDS epidemic
treatment model with saturated
incidence rate
7.1 Introduction
Mathematical modeling of epidemiological phenomena has become an important issue for
modern society. The needs of this modeling has far increased recently. Most of these
models are crucial and necessary to inform planning and policy formulation. In the
mathematical study of epidemiological problems, the incidence rate that measures the
rate of new infection is considered to be a very crucial parameter. It is assumed to be, in
most classical disease transmission models, of mass action type with bilinear interactions
given by βSI, where β is the per capita contact rate, and S and I represent the susceptible
and infected populations, respectively. However, the actual incidence S and I may not be
linear relationship. In [15], the following nonlinear incidence rate is used g(I) = βI(1+αI) to
the modeling of cholera. Nonlinearities can be approximated by a variety of forms kSI(1+aI2)
where kI measures the infection force of the disease and 1(1+αI2) describes the psychological
or inhibitory effect from the behavioural change of the susceptible individuals when the
112
http://etd.uwc.ac.za/
number of infectives is very large (k, α > 0). We investigate the stochastic dynamics of an
HIV/AIDS epidemic treatment model with saturated incidence rate and we will restrict
our attention the following saturated incidence rate and we refer to [48]
λsat = βiλ
where
λ = c(β1I + β2J)(1 + φ(I + J))
and with 1(1+φ(I+J)) measures the inhibition effect from behavioural change of susceptible
individuals when their number increases or from the crowing effect of the infective indi-
viduals [112]. The constant parameter φ measures the extent of psychological or inhitory
effect (detriment effect if 0 < φ < 1, beneficial or positive effect if φ > 1) [48]. For a very
large number of infective individuals, the force of infection may decrease as this number
increases due to the fact that in the presence of large number of infectives, the population
may tend to reduce the number of contacts per unit of time [112].
7.2 Preliminaries
Let us denote by Rn+ (resp. Rn++) the set of points in Rn having only non-negative (resp.
strictly positive) coordinates.
Throughout this paper we assume to have a complete probability space (Ω,F ,P) with a
filtration, {Ft}t≥0, that is right continuous and with F0 containing all the subsets having
measure zero.
Remark 7.2.1. We study the effect of stochastic noise in the transmission of HIV by
adding randomly fluctuation affecting directly the deterministic model. Suppose that infec-
tion rate β1 and β2 are stochastically perturbed with β1 → β1+σW˙ (t) and β2 → β2+σW˙ (t).
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7.3 HIV/AIDS stochastic model
Model system (7.1)
dS = [µK − λS − µS] dt− c(I + J)Sσ(1 + φ(I + J))dW (t)
dI = [λS − (µ+ k1)I + αJ ] dt+ cISσ(1 + φ(I + J))dW (t),
dJ = [k1I − (µ+ k2 + α)J ] dt+ cJSσ(1 + φ(I + J))dW (t),
dA = [k2J − (µ+ δ)A] dt. (7.1)
Let us define the following sets:
∆ =
{
x ∈ R4++ : x1 > 0, x2 > 0, x3 > 0, x4 > 0, and x1 + x2 + x3 + x4 ≤ K
}
Ω0 = {w ∈ Ω| A(t, w(t)) > 0 for all t ≥ 0}
Ω1 = {w ∈ Ω| (S(t, w(t)), I(t, w(t)), J(t, w(t)), A(t, w(t)) ∈ ∆ for t ≥ 0}.
Remark 7.3.1. Let us write N(t) = S(t) + I(t) + J(t) + A(t). Then N(t) is the total
population size, and satisfies the ordinary differential equation
d
dt
(K −N(t)) = µ(K −N(t))− δA(t).
Therefore it follows from solving the ordinary differential equation, that for any sample
path w ∈ Ω0, if we have N(0) ∈ ∆ then N(t) ∈ ∆. Note also that Ω1 ⊆ Ω0.
Theorem 7.3.2. For model (7.1) and an initial value (S(0), I(0), J(0), A(0)) ∈ ∆ with
all coordinates positive, there is a unique solution X(t) = (S(t), I(t), J(t), A(t)) with
X(t) ∈ ∆ for all t ≥ 0 with probability one.
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Proof. The coefficients of the system (7.1) are locally Lipschitz continuous. Thus there
exists a unique local solution on t ∈ [0, τen), where τen is the explosion time. Suppose that
we choose a number m0 ∈ N sufficiently large so that S(0), I(0), J(0), A(0) all lie within
the interval ( 1
m0
, K). For each n ∈ N ∩ [m0,∞), let us write
Dn =
{
t ∈ [0, τen) : S(t) ≤ 1
n
or I(t) ≤ 1
n
or J(t) ≤ 1
n
or A(t) ≤ 1
n
}
.
Then we define stopping times τn and τ∞ by taking τn to be the infimum of Dn if Dn 6= ∅
and otherwise τn =∞ . The set D∞ and the random variable τ∞ are defined as:
D∞ = {t ∈ [0, τen) : S(t) ≤ 0 or I(t) ≤ 0 or J(t) ≤ 0 or A(t) ≤ 0}
τ∞ = lim
n→∞ τn = inf D∞.
For each γ > 0, let Ω(γ) be the subset of Ω defined below.
Ω(γ) = {ω ∈ Ω|τ∞(ω) ≤ γ}
We shall prove by contradiction that τen = ∞ (a.s.). So let us assume to the contrary
that there exists T,C ∈ R with C > 0, and with T < τen such that P(Ω(T )) = C.
Let us define the function V (X), for X = (S, I, J, R), by the formula:
V (X) = ln
(
K4
SIJA
)
= ln K
S
+ ln K
I
+ ln K
J
+ ln K
A
By remark 7.3.1, each of the four terms of V (X(t)) are non-negative for every t ∈ [0, τ∞).
We set up a contradiction by calculating upper and lower bounds on expectations of V .
Firstly we calculate an upper bound. For every u ∈ [0, τ∞ ∧ T ) we have:
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dV (X(u)) = − 1
S(u)
{
[µK − λ(u)S(u)− µS(u)] du− c(I(u) + J(u))S(u)σ(1 + φ(I(u) + J(u)))dW (u)
}
+ 12S2(u)
[
c2(I(u) + J(u))2S2(u)σ2
(1 + φ(I(u) + J(u)))2
]
du− 1
I(u) {[λ(u)S(u)
−(µ+ k1)I(u) + αJ(u)] du+ cI(u)S(u)σ(1 + φ(I(u) + J(u)))dW (u)
}
+ 12I2(u)
[
c2(I2(u)S2(u)σ2
(1 + φ(I(u) + J(u)))2
]
du
− 1
J(u)
{
[k1I(u)− (µ+ k2 + α)J(u)] du+ cJ(u)S(u)σ(1 + φ(I(u) + J(u)))dW (u)
}
+ 12J2(u)
[
c2(J2(u)S2(u)σ2
(1 + φ(I(u) + J(u)))2
]
du
− 1
A(u) [k2J(u)− (µ+ d)A(u)] du. (7.2)
Removing some of the negative terms on the right hand side, we obtain the following
inequality.
dV (X(u)) ≤
[
λ(u) + 4µ+ k1 + k2 + α + δ +
1
2
c2(I(u) + J(u))2σ2
(1 + φ(I(u) + J(u)))2
+ c
2S2(u)σ2
(1 + φ(I(u) + J(u)))2
]
du
+
[
c(I(u) + J(u))σ
(1 + φ(I(u) + J(u))) − 2
cS(u)σ
(1 + φ(I(u) + J(u)))
]
dW (u) (7.3)
Note that since
1
(1 + φ(I(u) + J(u))) < 1,
I
(1 + φ(I(u) + J(u))) < K,
J
(1 + φ(I(u) + J(u))) < K
, then (7.3) becomes
dV (X(u)) ≤ ρdu+
[
c(I(u) + J(u))σ
(1 + φ(I(u) + J(u))) − 2
cS(u)σ
(1 + φ(I(u) + J(u)))
]
dW (u) (7.4)
where
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ρ = cK(β1 + β2) + 4µ+ k1 + k2 + α + δ +
1
2c
2(2K)2σ2 + c2K2σ2
= cK(β1 + β2) + 4µ+ k1 + k2 + α + δ + 3c2K2σ2,
and for t ∈ [0, τ∞ ∧ T ], let M(t) be as below.
M(t) = σ
∫ t
0
[
c(I(u) + J(u))
(1 + φ(I(u) + J(u))) − 2
cS(u)
(1 + φ(I(u) + J(u)))
]
dW (u).
Now we have the following inequality:
∫ t
0
dV (X(u)) ≤ ρt+M(t).
Therefore, for any k ∈ N ∩ [m0,∞) we have
V (X(t ∧ τk))− V (X(0)) ≤ ρ(t ∧ τk) +M(t ∧ τk) (a.s.)
The stochastic process M(t) is a local martingale and therefore for any m ∈ N ∩ [m0,∞)
we have E[M(t ∧ τm)] = M(0) = 0. Consequently,
E[V (X(T ∧ τm))] ≤ ρ(T ∧ τm) + V (X(0) ≤ ρT + V (X(0)),
and we have the upper bound which we set out to find. We now search for a lower bound
for E[V (X(T ∧ τm))]. Note that if ω ∈ Ω(T ) and we evaluate V (X(ζ)) for ζ = ω(τm), then
we get:
V (X(ζ)) ≥ ln(mK).
We can deduce the lower bound:
E[V (X(T ∧ τm))] ≥ C ln(mK).
These two bounds yield
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C ln(mK) ≤ E[V (X(T ∧ τm))] ≤ ρT + V (X(0)).
We can choose a value of m sufficiently big, so that
C ln(mK) > ρT + V (X(0)),
leading to a contradiction. Therefore we must have τ∞ =∞ almost surely. This complete
the proofs.
7.4 Exponential stability under large perturbation
Theorem 7.4.1. Assume that β = max{β1, β2}. If 12σ2 > β
2
(µ+δ) , then disease-free equi-
librium E0 = (K, 0, 0, 0) is almost surely exponentially stable in ∆.
Proof. Let (S0, I0, J0, A0) ∈ ∆. In virtue of theorem 7.3.2, the solution of the system 7.1
remains in ∆. Then let us define the function
V2 = ln [(K − S) + I + J + A] .
With the application of the multi-dimensional Itoˆ’s formula, it will result in the following
dV2 =
1
[(K − S) + I + J + A] [−dS + dI + dJ + dA]
−12σ
2
(
c(I + J)S
[(K − S) + I + J + A] [1 + φ(I + J)]
)2
dt
−12σ
2
(
cIS
[(K − S) + I + J + A] [1 + φ(I + J)]
)2
dt
−12σ
2
(
cJS
[(K − S) + I + J + A] [1 + φ(I + J)]
)2
dt (7.5)
.
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Further we have
dV2 = − [µ((K − S) + (I + J + A)) + δA][(K − S) + I + J + A] −
1
2σ
2
(
c(I + J)S
[(K − S) + I + J + A] [1 + φ(I + J)]
)2
dt
−12σ
2
(
cIS
[(K − S) + I + J + A] [1 + φ(I + J)]
)2
dt
−12σ
2
(
cJS
[(K − S) + I + J + A] [1 + φ(I + J)]
)2
dt
+ 2σc(I + J)S[(K − S) + I + J + A] [1 + φ(I + J)]dW
+
(
2c(β1I + β2J)S
[(K − S) + I + J + A] [1 + φ(I + J)]
)
dt
≤ − [µ((K − S) + (I + J + A)) + δA][(K − S) + I + J + A] −
1
2σ
2
(
c(I + J)S
[(K − S) + I + J + A] [1 + φ(I + J)]
)2
dt
+ 2σc(I + J)S[(K − S) + I + J + A] [1 + φ(I + J)]dW
+
(
2c(β1I + β2J)S
[(K − S) + I + J + A] [1 + φ(I + J)]
)
dt (7.6)
Letting Z =
(
c(I+J)S
[(K−S)+I+J+A][1+φ(I+J)]
)
. Then we write 7.6 by
dV2 ≤
[
−12σ
2Z2 + 2βZ − [µ((K − S) + (I + J + A)) + δA](K − S) + I + J + A
]
dt+ 2σZdW
≤
[
−12σ
2Z2 + 2βZ − (µ+ δ)
]
dt+ 2σZdW. (7.7)
where
β = max{β1, β2}.
Thus since −12σ2Z2 + 2βZ − (µ + δ) = −12σ2
(
Z − 2β
σ2
)2
+ 2β2−(µ+δ)σ2
σ2 , it can be deduced
that
dV ≤ 2β2−(µ+δ)σ2
σ2 + 2σZdW ,
and integrating we get
ln [(K − S(t)) + I(t) + J(t) + A(t)]
≤ ln [(K − S0) + I0 + J0 + A0] + 2β2−(µ+δ)σ2σ2 t+
∫ t
0 2σZdW.
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Note that the quadratic variation of the stochastic integral
∫ t
0 Z(s)dW0(s) is
∫ t
0 Z
2ds ≤ Ct;
for some constant C. Then by the strong law of large number for local martingales, see
[60], we have
lim
t→∞
1
t
∫ t
0
Z(s)dW (s) = 0 a.s. (7.8)
Therefore, it can be concluded that
lim
t→∞ sup
1
t
ln [(K − S(t)) + I(t) + J(t) + A(t)] ≤ 2β
2 − (µ+ δ)σ2
σ2
< 0
This completes the proof. 2
Remark 7.4.2. Assuming that φ = σ = 0, then the model system has the same basic
reproduction given in (3.3).
Theorem 7.4.3. If R0 < 1, then I(t), J(t) and A(t) converges exponentially to (0, 0, 0).
Proof. Let (S(0), I(0), J(0), A(0)) ∈ ∆. Since R0 < 1, let θ > 0 such that
θk2 < pi(1−R0)β2
where pi = (µ+ k1)(µ+ k2) + αµ.
Consider the following
V3 = ln(ξ1I(t) + ξ2J(t) + θA(t)) (7.9)
where ξ1 and ξ2 as defined in chapter 5.
By Itoˆ’s formula, we have the following
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dV3 =
1
ξ1I(t) + ξ2J(t) + θA(t)
[ξ1dI(t) + ξ2dJ(t) + θdA(t)]
− 12{[ξ1I(t) + ξ2J(t) + θA(t)][1 + φ(I + J)]}2 (ξ1σcIS)
2
− 12{[ξ1I(t) + ξ2J(t) + θA(t)][1 + φ(I + J)]}2 (ξ2σcJS)
2
≤ 1
ξ1I(t) + ξ2J(t) + θA(t)
[ξ1dI(t) + ξ2dJ(t) + θdA(t)]
≤ 1
ξ1I(t) + ξ2J(t) + θA(t)
(pi(R0 − 1)(β1I + β2J) + θdA(t))
+ σc(ξ1I + ξ2J)S[ξ1I(t) + ξ2J(t) + θA(t)][1 + φ(I + J)]
dW
≤ 1
ξ1I(t) + ξ2J(t) + θA(t)
[−pi(1−R0)Iβ1 − (pi(1−R0)β2 − θk2)J − (µ+ k2)θA]
σc(ξ1I + ξ2J)S
[ξ1I(t) + ξ2J(t) + θA(t)][1 + φ(I + J)]
dW
≤ −θ¯dt+ 1[ξ1I(t) + ξ2J(t) + θA(t)][1 + φ(I + J)]σc(ξ1I + ξ2J)SdW (7.10)
Where θ¯ = max(pi(1−R0)β1, (pi(1−R0)β2 − θk2), (µ+ k2)θ). By integrating we check
ln(ξ1I(t) + ξ2J(t) + θA(t))
≤ ln(ξ1I0 + ξ2J0 + θA0)− θ¯t
+
∫ t
0
σc(ξ1I(s) + ξ2J(s))S(s)
[ξ1I(s) + ξ2J(s) + θA(s)][1 + φ(I(s) + J(s))]
dW (s) (7.11)
We note in particular that in view of the strong law of large number for local martingales
[60], the last terms of (7.11) will vanish a.s.
Therefore, we can deduce that
lim
t→∞ sup
1
t
ln(ξ1I(t) + ξ2J(t) + θA(t)) ≤ −θ¯ < 0.
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This complete the proof.
7.5 Numerical simulations
We present some numerical simulations and we refer to the table 5.1. In order to find the
equilibrium point, let us first consider the following equilibrium values for I and J :
I = (α + µ+ k2)Kλµ(λ+ µ) ((µ+ k1) (µ+ k2) + αµ)
and
J = 1(α + µ+ k2)
[
k1
(α + µ+ k2)Kλµ
(λ+ µ) ((µ+ k1) (µ+ k2) + αµ)
]
where
λ = c(β1I + β2J)[1 + φ(I + J)].
Thus, our initial state is taken as:
S0 = 49.12, I0 = 5.11, J0 = 1.35, A0 = 0.23.
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Figure 7.1: Stochastic perturbation with φ = 0.90
Chosen values: β1 = 0.000176, β2 = 0.00037, σ = 0.03. Calculated value: R0 = 0.9616.
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Figure 7.2: Decreasing φ by 0.20
Chosen values: β1 = 0.000176, β2 = 0.00037, σ = 0.03. Calculated value: R0 = 0.9616.
In both figures 7.1 and 7.2, we choose the same value of stochastic perturbation σ = 0.03.
The basic reproduction number is found to be R0 < 1. In this case, the disease-free
equilibrium is almost surely exponential stable. It can be seen that the number of infected
individuals in figure 7.2 is higher than in figure 7.1 due to decreasing the value of φ by
0.20, but in both cases the requirements of Theorem 7.4.1 are satisfied.
7.6 Conclusion
This paper presents a stochastic model describing the population dynamics of an HIV/AIDS
epidemic. Our aim is to study the effect of stochastic noise and that of the saturated in-
cidence rate in the transmission of HIV, i.e., stochasticity associated with the parameters
β1 and β2. We proved the almost sure exponential stability of the model system under
suitable conditions. In particular, we proved that the stochastic perturbation does not
destabilize the disease-free equilibrium, that is to say, whenever R0 < 1, then the disease-
free equilibrium is almost surely exponentially stable. Our future work should analyze
other types of stability such as the pth moment exponential stability and in more complex
compartmental models.
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Chapter 8
Exponential stability of a
disease-free for an HIV epidemic
model with the use of prophylaxis
Submitted for publication.
8.1 Introduction
Pre-exposure prophylaxis has become a very promising approach for the HIV prevention
from infected individuals. However, the risk infection with HIV after exposure to a virus
can be better understood through a stochastic framework. In this research, we present a
stochastic model for HIV/AIDS epidemic with the use of prophylaxis and we show that
the model with random perturbation has a unique global positive solution. Thereafter, we
introduce an analogue of the basic reproduction number, call it Rσ to support a theorem
on almost sure exponential stability. The latter asserts that the disease free goes extinct
exponentially almost surely whenever Rσ < 1. The results show that small stochastic
perturbations predict disease extinction rather than persistence.
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The following papers, see for instance in [26, 38, 105, 106, 16] show that stochastic per-
turbations can further improve the quality stability of the disease-free equilibrium for
the specific models. However, stochastic models of HIV/AIDS population dynamics in-
cluding ARV treatment and Pre-exposure prophylaxis have not been intensively studied.
The current paper aims to demonstrate how the use of PrEP may lead to reducing new
infections for instance, and even in the presence of minor stochastic perturbations. Our
motivation in this chapter comes from the fact that stochastic framework may have the
ability to predict efficacy of prophylaxis against HIV.
In section 8.2 , we show the model and prove positivity. In Section 8.3 we present a theo-
rem on almost sure exponential stability. We provide numerical simulations to in Section
8.4 . In Section 8.5 we present some concluding remarks.
8.2 HIV stochastic Model
Throughout this paper we assume to have a complete probability space (Ω,F ,P) with
a filtration, {Ft}t≥0, that is right continuous and F0 containing all the subsets having
measure zero.
Let B(t) = (B0(t), B1(t), B2(t), B3(t), B4(t)) be a 5-dimensional Wiener process defined
on the given probability space. The non-negative constants σ0, σ1, σ2, σ3 and σ4 denote
the intensities of the stochastic perturbations. We shall assume that the components of
the 5-dimensional Wiener process Bi are mutually independent. In the model, we also
introduce two positive constants r and q such that r2 + q2 = 1 and r >
√
2
2 . We have the
following model system:
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dS(t) = [µK − λS(t)− (µ+ φ)S + θE]dt+ σ0S(t)dB0(t),
dI1(t) = [λS(t)− (µ+ k1)I1(t) + αI2(t)]dt+ σ1rI1(t)dB1(t),
dI2(t) = [k1I1(t)− (µ+ k2 + α)I2(t)]dt+ σ2qI2(t)dB2(t),
dA(t) = [k2I2 − (µ+ δ)A]dt+ σ3A(t)dB3(t)
dE(t) = [φS − (µ+ θ)E]dt+ σ4E(t)dB4(t) (8.1)
where
λ = c(β1I1(t) + β2I2(t)).
We now show that solutions of (8.1) exist globally and are positive, but first let us write:
Rn++ = {x ∈ Rn|xi > 0 for all i = 1, 2, .., n}. (8.2)
Theorem 8.2.1. For model (8.1) and any initial value (S(0), I1(0), I2(0), A(0), E(0)) ∈
R5++, there is a unique solution (S(t), I1(t), I2(t), A(t), E(t)) on t ≥ 0 which remains in
R5++ with probability one.
Proof. Consider the function V1 as defined below
V1(S, I1, I2, A,E) =
(
S − a0 − a0 ln S
a0
)
+
(
I1 − 1− ln I2
)
+
(
I2 − 1− ln I2
)
+
(
A− 1− lnA
)
+
(
E − 1− lnE
)
.
By applying Itô’s formula as in the proof Theorem 4.3.1, we have:
dV1(S, I1, I2, A,E) = LV1dt+ (S − a0)σ0dB0(t) + (I1 − 1)rσ1dB1(t)
+(I2 − 1)qσ2dB2(t) + (A− 1)σ3dB3(t)
+(E − 1)σ4dB4(t), (8.3)
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where
LV1 =
[(
1− a0
S
)(
µK − c(β1I1 + β2I2)S − (µ+ φ)S + θE
)]
+
[(
1− 1
I1
)(
c(β1I1 + β2I2)S
−(µ+ k1)I1 + αI2
)]
+
[
(1− 1
I2
)(k1I1 − (µ+ k2 + α)I2)
]
+
[
(1− 1
A
)(k2J − (µ+ δ)A)
]
+
[
(1− 1
E
)(φS − (µ+ θ)E)
]
+12
(
a0σ
2
0 + r2σ21 + q2σ22 + σ23 + σ24)
= µK − a0
S
µK − µ(S + I1 + I2 + A+ E)− a0
S
θE + a0(µ+ φ) + a0c(β1I1 + β2I2)
− 1
I1
c(β1I1 + β2I2)S + (µ+ k1)− 1
I1
αI2 + (µ+ k2 + α)− 1
A
k2J + (µ+ δ)
− 1
E
φS + (µ+ θ).
Now we note that we have an upper bound for LV1
LV1 ≤ µK − µ(I1 + I2) + a0c(β1I1 + β2I2) + 4µ+ a0(µ+ φ) + k1 + k2 + α + δ + θ
+12
(
a0σ
2
0 + r2σ21 + q2σ22 + σ23 + σ24).
We choose a0 > 0 sufficiently small in order to have
a0cβ1I1 − µI1 = I1 (a0cβ1 − µ) < 0 and a0cβ2I2 − µI2 = I2 (a0cβ2 − µ) < 0.
Therefore
LV1 ≤ C,
where C = µK + 4µ+ a0(µ+ φ) + k1 + k2 + α+ δ+ θ+ 12 (a0σ
2
0 + r2σ21 + q2σ22 + σ23 + σ24)
is a constant.
The rest of the proof follows readily.
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The following subset Φ of sample paths will be of interest.
Φ =
{
ω ∈ Ω| (S(t, ω), I1(t, ω), I2(t, ω), A(t, ω), E(t, ω)) ∈ R5++ for all t ≥ 0
}
.
From Theorem 8.2.1 it follows that P(Ω\Φ) = 0. In the remainder of this section we
assume that sample paths are restricted to Φ.
8.3 Almost sure exponential stability
In the following, we introduce some more concepts leading to the preparation of our main
theorem on almost sure exponential stability.
Let us first assume that σ0 = σ4 = 0, then the model system (8.1) exhibits a disease-free
equilibrium E0 = ( (µ+θ)K(µ+φ+θ) , 0, 0, 0,
φK
(µ+φ+θ)). Note that condition σ0 = σ4 = 0 is also in line
with section 5.4. In this case the basic reproduction number is computed by
R0 = c(µ+ θ)Kβ1b1(µ+ φ+ θ)b4 (8.4)
where
b1 = (µ+ k2 + α + k1
β2
β1
), b4 = ((µ+ k1)(µ+ k2) + αµ).
Remark 8.3.1. The function that we now introduce links R0 and Rσ. Let us define
h : R++ → R+ by the rule x→ 1
x
[r2x2b21 + q2(1− b21x2)] (8.5)
with b1 as in (8.4).
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If r = q =
√
2
2 , then h(x) =
1/2
x
. In this case h tends 0+ as x approaches +∞. In our proof,
we omit the case where both are equal. Further, it is easy to see that for r 6= q, then h
tends +∞ as x tends +∞; h tends to +∞ as x tends to 0+. Therefore, h′(x) is continuous
on R++ and has the following root denoted by x0 = q
2
b1
√
2r2−1 . Therefore, h
′′(x0) > 0 to
indicate that h(x) has a minimum given by
h(r∗) = b1r
2
√
2r2 − 1 .
At the end of the proof for our main theorem, we shall use the fact that
Rσ = c(µ+ θ)Kβ1b1(µ+ φ+ θ)(b4 + min{σ12, σ22}h(r∗))
. (8.6)
Proposition 8.3.2. If (S(0), I1(0), I2(0), A(0), E(0)) ∈ R5++, then almost surely, S(t) +
E(t) ≤ K for all t > 0.
Proof. Given any path (in Φ), then
d((S + E)−K)
dt
= −µ((S + E)−K)− c(β1I1 + β2I2)S ≤ −µ((S + E)−K).
Therefore S(0) + E(0) < K implies that S(t) + E(t) < K for all t > 0.
Consider the numbers b0, b1, b2, b3, b4 and b5
where
b1 = (µ+ k2 + α + k1
β2
β1
), b2 = α +
β2
β1
(µ+ k1) + b5
b3 = b4
(1−R0)
k2
, b4 = ((µ+ k1)(µ+ k2) + αµ)
b5 =
(1−R0)
k1
. (8.7)
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Note that we choose b0 sufficiently small such that
b0cβ1Λ +
b4
2 (R0 − 1) < 0
and
b0cβ2Λ− b5(µ+ k2 + α) < 0,
where Λ = (µ+θ)K(µ+φ+θ) .
Using the numbers bi introduced, we can now define a function Z(t) below. Recall that
as we work with sample paths in Φ, this implies in particular that Z(t) > 0 for all t ≥ 0.
Thus we define
Z(t) = b0(K − (S(t) + E(t)) + b1I1(t) + b2I2(t) + b3A(t) (8.8)
and let
V2(t) = lnZ(t).
For a stochastic process x(t) we write
〈x〉t =
1
t
∫ t
0
x(s)ds.
Proposition 8.3.3. The disease-free equilibrium of model system (8.1) is almost surely
exponentially stable if
lim sup
t→∞
〈LV2(X)〉t < 0 (a.s.).
Proof. We start off by noting that
V2(X(t)) = V2(X(0)) +
∫ t
0
LV2(X(u))du+Mt,
where
130
http://etd.uwc.ac.za/
Mt =
∫ t
0
(
−b0σ0 S(u)
z(X(u))dB0(u) + b1rσ1
I1(u)
z(X(u))dB1(u) + b2qσ2
I2(u)
z(X(u))dB2(u)
+b3σ3
A(u)
z(X(u))dB3(u)− b0σ4
E(u)
z(X(u))dB4(u)
)
The strong law of large numbers for local martingales, see [60, p12] for instance, implies
that
lim
t→∞
1
t
Mt = 0 (a.s.).
Also, we observe that
lim
t→∞
1
t
V2(X(0)) = 0.
Therefore
lim sup
t→∞
1
t
V2(X(t)) = lim sup
t→∞
1
t
∫ t
0
LV2(X(u))du = lim sup
t→∞
〈LV2(X)〉t (a.s.).
This completes the proof.
We now calculate LV2.
LV2 = −µb0 [K − (S + E)]
Z
+ I1
Z
[(b0 + b1)cβ1S − b1(µ+ k1) + b2k1]
+I2
Z
[(b0 + b1)cβ1S + b1α− b2(µ+ k2 + α) + b3k2]
−b3(µ+ δ)A
Z
− 12Z2
(
r2b21σ
2
1I
2
1 + q2b22σ22I22 + b23σ23A2
)
≤ C0 [K − (S + E)]
Z
+ C1
I1
Z
+ C2
I2
Z
+ C3
A
Z
− 12Z2
(
r2b21σ
2
1I
2
1 + q2b22σ22I22
)
.
By Lemma 2.3 in [106], we can find, for every sample path w of the Wiener process W (t),
there exists an unbounded increasing sequence tn of positive time values for which
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lim sup
t→∞
LV2(t, w) = lim
n→∞LV2(tn, w),
and for which we can define the following limits:
s = lim
n→∞ 〈S〉tn , i1 = limn→∞
〈
I1
Z
〉
tn
, i2 = lim
n→∞
〈
I2
Z
〉
tn
, a = lim
n→∞
〈
A
Z
〉
tn
,
and
q = lim
n→∞
〈
K − (S + E)
Z
〉
tn
.
In particular we note the identity
b0q + b1i1 + b2i2 + b3a = 1 (8.9)
and
b0q, b1i, b2j, b3a ∈ [0, 1].
We define F (b) as:
F (b) = F (b0, b1, b2, b3) = lim sup
t→∞
LV2(t).
Then F (b) takes the form:
F (b) = C0q + C1i1 + C2i2 + C3a− 12
(
r2b21σ
2
1i
2
1 + q2b22σ22i22
)
≤ C0q + C1i1 + C2i2 + C3a− 12 min{σ
1
2, σ
2
2}
(
r2b21i
2
1 + q2b22i22
)
(8.10)
with s < (µ+θ)K(µ+φ+θ) = Λ and where
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C0 = −b0µ < 0
C1 = b0cβ1Λ + b4(R0 − 1) + k1b5
= b0cβ1Λ +
b4
2 (R0 − 1) < 0
C2 = b0cβ2Λ + b4(R0 − 1) + k2b3 − b5(µ+ k2 + α)
= b0cβ2Λ− b5(µ+ k2 + α) < 0
C3 = −(µ+ δ)b3 < 0.
Remark 8.3.4. From the identity (8.9), we also have the inequality
(b2i2)2 ≤ (1− b1i1)2
≤ (1− b21i21),
and with h(.) being the function as in equation (8.6), then the last term of (8.10) can be
written as:
(r2b21i21 + q2b22i22) = i1h(i1).
Therefore from C1 we have the inequality
b0cβ1Λ +
1
2[b4 + min{σ
1
2, σ
2
2}h(r∗)](Rσ − 1) < 0.
Theorem 8.3.5. Assuming Rσ < 1, then (I1(t), I2(t), A(t)) almost surely converge expo-
nentially to 0.
Proof. Note that by the choice of b0, it follows that
b0cβ1Λ +
1
2
cK(µ+ θ)b1
(µ+ φ+ θ) −
1
2b4 −
1
2 min{σ
1
2, σ
2
2}h(r∗) < 0.
Thus
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F (b) ≤ −b0µq + i1[b0cβ1Λ + 12(b4 + min{σ
1
2, σ
2
2}h(r∗))(Rσ − 1)]− i2b5(µ+ k2 + α)
−a(µ+ δ)b3 < 0.
This completes the proof.
8.4 Numerical simulation
We use parameters and initial states values given in [70]. The parameters values are as
follows:
Table 8.1: List of parameters and their values chosen to simulate the model system (8.1)
based on the South African historical HIV trend.
Parameters Value Source
α 0.33 [9]
k1 0.125 [41]
k2 0.1 [9]
c 3 cf. [40]
δ 0.279 [90]
µ 162.4 [90]
φ 0.01 Nominal
θ 0.001 Nominal
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We assign the following initial values:
S0 = 56.18, E0 = 1.12, I1,0 = 5.11, I2,0 = 1.43, A0 = 0.48
In the following we only show the trajectories of I2(t) for different values of φ, φ =
0.02, 0.021. For the different values of φ, the corresponding value of R0 will be denoted
by R0(φ).
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Figure 8.1: Convergence beyond R0(φ) < 1.
Chosen values: β1 = 0.000481, β2 = 0.000581, σ1 = 0.03, σ2 = 0.03. Calculated values:
R0(0.02) = 1.021,Rσ = 0.726
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Figure 8.2: Convergence to the disease-free equilibrium.
Chosen values: β1 = 0.000481, β2 = 0.000581, σ1 = 0.03, σ2 = 0.03. Calculated values:
R0(0.021) = 0.9975,Rσ = 0.7124.
.
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Figure 8.3: Improving stability of the disease-free equilibrium.
Chosen values: β1 = 0.000481, β2 = 0.000581, σ1 = 0.04, σ2 = 0.05. Calculated values:
R0(0.021) = 0.9975,Rσ = 0.5872.
In Figure 8.1, for φ = 0.02 and σ1 = σ2 = 0.03, R0(0.02) = 1.021 while Rσ = 0.726 < 1.
In this case, Theorem 8.3.5 guarantees almost sure exponential stability. Indeed there
is convergence to the disease-free equilibrium even beyond R0(φ) < 1. The substantial
change which occurred in the value of the basic reproduction number is due to both in-
creasing uptake of PrEP and the stochastic perturbations, which led to decreasing the
value of the the class of I2(t). In Figure 8.2, for σ1 = σ2 = 0.03 and an increase in
the uptake of PrEP to φ = 0.021 results in decreasing the basic reproduction number to
R0(0.02) = 0.9975 < 1 while Rσ = 0.726 < 1. The disease-free equilibrium is almost
sure exponentially stable. In Figure 8.3, we increase the values σ1 = 0.04, σ2 = 0.05 and
Rσ = 0.5872 < 1. In this case, we have expected the disease to converge faster to zero
according to the theorem.
8.5 Concluding remarks
In this chapter, we investigated a stochastic model describing the population dynamics
of HIV with pre-exposure prophylaxis (PrEP). We proved existence of solutions which
are almost surely global and positive by using Lyapunov techniques. We also proved a
theorem (Theorem 8.3.5) on almost exponential stability. From the main theorem (The-
orem 8.3.5), we found that the disease-free equilibrium is almost surely exponentially
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stable whenever the requirement is fulfilled. The simulations show that minor stochastic
perturbations on the model may not always be catastrophic, and this has been observed
in the simulations. Thus, minor environmental perturbations may not stop public health
authorities from deciding on launching of a certain programme. Our model has attempted
to show how the use of PrEP can potentially reduce the number of new HIV infections,
and even when minor stochastic perturbations are considered.
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Chapter 9
Concluding remarks and scope for
future research
It has been shown throughout the literature that the greatest burden of HIV/AIDS is
still in sub-Saharan Africa and in this region, especially women are severely affected.
South Africa has more people infected with HIV, but the country has kept more HIV-
infected people alive than any other country by providing access to anti-retroviral therapy
(ART) in the public sector and negotiating drug prices [104]. Anti-retroviral Treatment
(ART) can help to reduce HIV transmission. The substantial impact of treatment on
the incidence, prevalence and mortality shows how it is imperative to make ARV treat-
ment available to everyone, regardless of CD4+ cell counts. It is also known that early
ARV treatment eliminates HIV transmission and possibly eliminates AIDS related deaths.
Thus, HIV/AIDS can be considered as a chronic manageable disease rather than a fatal
one.
However, the HIV/AIDS epidemic addresses a complex challenge to the public policy of
South Africa, with implications for some of the government’s key policy objectives (no-
tably health, education, social development), and impacts on public finance and macroe-
conomic. There is a range of fiscal consequences resulting from HIV/AIDS beyond the
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costs of the policy response. An important aspect of the fiscal costs of HIV/AIDS is the
fact that the costs of HIV/AIDS impacts and its national response are highly persistent-
not only absorbing a considerable share of fiscal resources at present, but projected to
continue doing so over many years [24].
Our dissertation deals with stochastic modeling an HIV/AIDS epidemic disease with
treatment. The dynamics of the model are also studied when there is a massive inflow of
HIV infectives.
We start off with the underlying deterministic model in Chapter 3. We extend the paper
of cai et al. [14] and we prove both global stability of endemic and disease-free equilibrium
with and without the inflow of infectives respectively. We prove existence of the endemic
equilibrium as well. We carry out with stability analysis and we support our theoretical
results by way of numerical simulations. Through the numerical simulations, we show the
impact that the inflow have on the transmission of HIV. The disease in this case remain
at the endemic level and the model system does not exhibit a disease-free equilibrium.
Explicit inclusion of stochastic perturbations into epidemiological models by way of Brow-
nian motion shows much insight into the problem since randomness does feature in real
life. Stochasticity has been introduced in various biological models such as for instance,
natural resource management or the ecological studies or the epidemics in human popu-
lations. In Chapter 4, a stochastic model for the population dynamics of HIV/AIDS is
introduced and we show that there are feasible solutions (almost surely) in every sense
that we have explored. We also investigate the asymptotic behaviour of the solutions
with respect to the disease-free equilibrium of the underlying deterministic model. Our
results have shown that minor random noise predicts extinction of the disease rather than
persistence.
In Chapter 5, We have presented an sde model of HIV with inflow of infectives. In the
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special case that we have no inflow of infectives into the system and σ0 = 0, and for
sufficiently small values of the perturbation parameter, stability of the disease-free equi-
librium is obtained for a bigger range of values of the basic reproduction number R0 of
the deterministic model, i.e., beyond the range R0 < 1. This is sufficiently significant
that it can be observed in simulations. The almost sure exponential stability is a fairly
strong type of stability, it being a stochastic version of global asymptotic stability. For the
public health authorities it is comforting to know that the presence of minor stochasticity
on their model will not be a hindrance if eradication strategies should be launched. In the
case of stochastic HIV/AIDS model with inflow of infectives, we have been able to study
stability in the mean. The theorem asserts that asymptotically the stochastic solutions
stay within a certain bound from the (non-trivial) equilibrium point of the underlying
deterministic model.
In Chapter 6, we have established a model describing the population dynamics of HIV/AIDS
including treatment and pre-exposure prophylaxis (PrEP) in the context of South Africa.
Our analytical results and our sample simulations are quite meaningful as we work with
the current HIV trend in South Africa. Our model quantifies how the use of PrEP can
potentially reduce the number of new HIV infections, and this has been well observed in
the sample simulations. South Africa has a wide range of its population being exposed to
HIV. Its high-risk sections of the population include adolescent girls and young women,
sex workers, men who have sex with men (MSM), discordant couples and truckers, all of
whom face various barriers to access including stigma, criminalisation and lack of sup-
portive service delivery infrastructure [21]. If they are to be the focal point for PrEP, it
will be imperative to assess how best to introduce PrEP into programmes where these
high risk sections of the population can be supported [22].
The incidence rate that measures the rate of new infection is considered to be a very
crucial parameter. In Chapter 7 we introduce a stochastic model for HIV/AIDS with
incidence rate., stochasticity associated with the parameter β. Thus by constructing
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suitable Lyapunov functions and applying Itoˆ’s formula, some other properties such as
existence of global positive solution, convergence, almost sure exponential stability are
proved. Our theoretical results are supported by ways of numerical simulations. Our
results show stochastic perturbation can predict extinction rather than persistence. We
also show that when inhibitory effect from the behavioural change of the susceptible in-
dividuals is large then the force of infections becomes small.
In chapter 8, we present a stochastic model for HIV/AIDS epidemic with the use of
prophylaxis and we show that the model with random perturbation has a unique global
positive solution. Our motivation in this research comes from the fact that stochastic
framework may have the ability to predict efficacy of prophylaxis against HIV.
The effects of different environmental noises from the underlying deterministic model may
lead to different dynamical outcomes. In the case of HIV models, we may have to extend
to the approach in [84] to illustrate the different dynamical outcomes of two stochastic
differential equation models based on simulation observations and the theorems obtained
from previous sections. Following the approach for instance in [84], then the HIV/AIDS
perturbed can be written as
dS = [µK − c(β1I1 + β2I2)S − µS] dt+ σ00SdW00(t) + σ01I1dW01(t)
+σ02I2dW02(t) + σ03AdW03(t)
dI1 = [c(β1I1 + β2I2)S − (µ+ k1)I1 + αI2] dt+ σ10SdW10(t) + σ11I1dW11(t)
+σ12I2dW12(t) + σ13AdW13(t)
dI2 = [k1I1 − (µ+ k2 + α)I2] dt+ σ20SdW20(t) + σ21I1dW21(t)
+σ22I2dW22(t) + σ23AdW23(t)
dA = [k2I2 − (µ+ δ)A] dt+ σ30SdW30(t) + σ31I1dW31(t)
+σ32I2dW32(t) + σ33AdW33(t).
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where σij, i, j = 0, 1, 2, 3 are real constants and known as the intensity of environmental
fluctuations, Wij(t), i, j = 0, 1, 2, 3 independent standard Brownian motion. For simplic-
ity, the dynamics of the model can also be studied when the values of σij = σj, i = 0, 1, 2, 3.
Mathematical modeling has been such an important approach to control the population
dynamics of infectious diseases. Optimal control has been applied by many mathemati-
cians in the analysis and control of infectious diseases both qualitatively and quantita-
tively. In particular, the study on optimal control aims to determine the best method
of controlling the outbreak of certain disease for instance within a specific time frame.
Our future work will formulate an optimal control problem for both deterministic and
stochastic cases where the objective would be to determine the ARV treatment strategy
and PrEP strategy that minimize the class of individuals with HIV as well as the costs
associated with ARV treatment and PrEP. The outbreak of HIV/AIDS has led to an
increasing awareness among economists of the need to study their impact on the economy
in terms of the resources allocation and cost. This question arises when the resources
available for public healthcare are strictly limited. If resources are unlimited, then the
optimal way to allocate prevention funds is to spend enough to eradicate the disease. An-
other approach that we aim to research on is the cost-effectiveness analysis (CEA). CEA
is a type of economic analysis where both the cost and the outcome (impact, result, effect,
benefit, health gain) of an intervention are evaluated and then expressed in the form of a
cost-effectiveness ratio. The numerator of the cost-effectiveness (CE) ratio represents the
cost of the intervention associated with one unit of outcome. The denominator is the unit
of outcome. It can be expressed using many types of measures including: years of life
gained, quality-adjusted life years gained (QALY s), new diagnoses, infections averted,
and deaths averted. CEA is usually conducted on interventions that are known to be ef-
fective. In recent years, mathematical models with the inclusion of latent infected T-cells
have been developed to investigate the models behaviors. Many of these models do not
consider the effect of stochastic fluctuation factor which is such an important component
in epidemiological modeling. Research related to stochastic differential equation model of
the dynamics mechanism of HIV virus can be very meaningful with experimental data.
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Stochastic models of HIV co-infection with malaria, Tuberculosis or flu will also be at
centre of our future research. Another version of stochastic model can also be formulated
by using the continuous-time discrete state Galton-Watson branching process (GWbp).
The branching process helps to determine disease invasion and extinction probabilities.
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